nad has been researched along with Disease Models, Animal in 314 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (7.32) | 18.7374 |
1990's | 22 (7.01) | 18.2507 |
2000's | 60 (19.11) | 29.6817 |
2010's | 150 (47.77) | 24.3611 |
2020's | 59 (18.79) | 2.80 |
Authors | Studies |
---|---|
Kang, H; Kim, MB; Lee, JY; Park, YK | 1 |
Cappetta, D; De Angelis, A; Di Pietro, P; Fasano, S; Marino, M; Meccariello, R; Mele, E; Paciello, O; Piegari, G; Pierantoni, R; Santoro, A; Scafuro, M; Troisi, J; Vecchione, C; Viggiano, A | 1 |
Bradley, J; Cheng, C; Jin, T; Li, H; Liang, L; Mangino, MJ; Ornato, JP; Peberdy, MA; Su, C; Tang, W; Xiao, Y; Zhang, G | 1 |
Ge, J; Gu, L; Liu, Y; Wang, H; Wang, Q; Wu, X; Zhu, S | 1 |
Podyacheva, E; Toropova, Y | 1 |
Belosludtsev, KN; Belosludtseva, NV; Khunderyakova, NV; Kireeva, TA; Mironova, GD | 1 |
Armistead, J; Cabas, I; Cantón-Sandoval, J; Cayuela, ML; Corbalán-Vélez, R; García-Ayala, A; García-Borrón, JC; García-Moreno, D; Hammerschmidt, M; Hatzold, J; Lacal, J; López-Muñoz, A; Martínez-Menchón, T; Martínez-Morcillo, FJ; Martínez-Navarro, FJ; Martínez-Vicente, I; Mulero, V; Pérez-Oliva, AB | 1 |
Cao, W; Khadka, D; Kim, HJ; Kwak, TH; Lee, SB; Lee, SH; Oh, GS; Park, BO; Shim, H; So, HS; Yoon, CH; Zhu, MY | 1 |
Guo, L; Li, B; Song, X; Sun, P; Tan, G; Wang, J; Zhang, N | 1 |
Ajo-Franklin, CM; Anaya-Sanchez, A; Deng, D; Light, SH; Portnoy, DA; Reyes Ruiz, VM; Rivera-Lugo, R; Sauer, JD; Skaar, EP; Smith, HB; Tang, E; Tejedor-Sanz, S; Titov, DV | 1 |
Hua, L; Liu, M; Liu, Y; Lu, H; Ma, W; Tang, Y; Wang, G; Wang, L; Wu, C; Xi, S; Yao, H; Zhang, R; Zu, Y | 1 |
Cao, J; Deng, C; Deng, Q; Ding, X; Guo, C; Liu, Q; Qiu, L; Tian, B; Ye, C; Zhang, X; Zhang, Y | 1 |
Cai, J; Chen, S; Gu, X; Hua, L; Li, C; Li, F; Liu, M; Liu, T; Lu, H; Tang, Y; Wang, G; Wang, L; Wang, S; Wu, C; Xi, S; Xing, GG; Xiong, W; Yang, M; Yao, H; Zhang, R; Zu, Y | 1 |
Sheng, T; Wang, Y; Ye, Y; Yu, P; Zhang, F; Zhu, X | 1 |
Bais, P; Bult, CJ; Burgess, RW; Cox, GA; Doty, R; Fiehn, O; Hatton, CL; Hoffmann, BR; John, SWM; Morelli, KH; Murray, GC; Pratt, SL; Schroeder, D; Stodola, TJ; Tadenev, ALD | 1 |
Canto, C; Cercillieux, A; Ciarlo, E | 1 |
Chen, LY; Gil Alabarse, P; Liu-Bryan, R; Oliveira, P; Qin, H | 1 |
Li, Y; Liu, J; Liu, X; Luo, D; Luo, M; Qin, S; Tian, F; Wang, H; Yang, M | 1 |
Ejtemaei-Mehr, S; Ghahremani, MH; Ghanbari, A; Ghazi-Khansari, M; Guillemin, GJ; Jand, Y | 1 |
Antosiewicz, J; Cieminski, K; Dzik, KP; Flis, DJ; Kaczor, JJ; Wieckowski, MR; Ziolkowski, W | 1 |
Bragin, DE; Bragina, OA; Kameneva, MV; Monickaraj, F; Nemoto, EM; Noghero, A; Trofimov, AO | 1 |
Bragin, DE; Bragina, OA; Kameneva, MV; Nemoto, EM; Sillerud, LO | 1 |
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
Huang, K; Lee, CS; Lee, HC; Li, WH; Zhao, YJ; Zhu, WJ | 1 |
Fu, Y; Gong, Y; Jiang, Y; Luo, Y; Luo, Z | 1 |
Gasior, FM; Justice, CN; Lee, C; Li, J; Lin, S; O'Donnell, JM; Vanden Hoek, TL; Wang, H; Zhu, X | 1 |
Germeraad, WTV; Kondo, T; Murata, T; Otsuka, R; Seino, KI; Wada, H | 1 |
Alrowaished, SS; Bailey, EC; Belanger, JJ; Crooks, ES; Drinkert, DM; Henry, CA; Karunasiri, CM; Kelley, JB; Khalil, A; Kilroy, EA | 1 |
Boutant, M; Canto, C; Cercillieux, A; Giner, MP; Giroud-Gerbetant, J; Joffraud, M; Kulkarni, SS; Moco, S; Ratajczak, J; Sambeat, A; Sanchez-Garcia, JL; Valera-Alberni, M; Valsesia, A | 1 |
Chen, C; Hu, Y; Huang, X; Shen, D; Xing, S | 1 |
Agarwal, G; Ahmadieh, S; Benjamin, S; Benson, TW; Blomkalns, AL; Edgell, A; Fulton, DJ; Gilreath, N; Horimatsu, T; Huo, Y; Kim, D; Kim, HW; Mann, A; Moses, M; Offermanns, S; Ogbi, M; Patel, S; Pye, J; Reid, L; Robbins, N; Singh, N; Stansfield, BK; Thompson, A; Weintraub, NL | 1 |
Aman, Y; Bohr, VA; Caponio, D; Croteau, DL; Demarest, TG; Fang, EF; Figueroa, D; Filippelli, D; Hou, Y; Jasper, H; Jensen, MB; Kassahun, H; Kato, H; Khezri, R; Lautrup, S; Lee, HJ; Lee, JH; Lyssiotis, CA; Maezawa, Y; Mangerich, A; Mattson, MP; Morevati, M; Nilsen, H; Okur, MN; Rusten, TE; SenGupta, T; Tao, J; Yang, B; Yokote, K | 1 |
Chen, Y; Cho, GJ; Choi, HS; Chung, HT; Joe, Y; Kim, HJ; Kim, UH; Park, J; Park, JW; Rah, SY; Ryter, SW; Ryu, J | 1 |
Auwerx, J; Harlan, BA; Killoy, KM; Liu, L; Pehar, M; Vargas, MR | 1 |
Braidy, N; Chiang, S; Dharmasivam, M; Huang, MLH; Kalinowski, DS; Richardson, DR | 1 |
Coleman, MP; Höke, A | 1 |
Bowie, A; Campbell, M; Carty, M; Doyle, SL; Gibbons, L; Humphries, M; Humphries, P; Kenna, P; Monaghan, M; Neto, NG; Ozaki, E | 1 |
Abdullah, L; Crawford, F; Cseresznye, A; Darcey, T; Evans, JE; Joshi, U; Keegan, AP; Klimas, N; Mouzon, B; Mullan, M; Oberlin, S; Ojo, J; Paris, D; Pearson, A; Saltiel, N; Sullivan, K | 1 |
Ayuso, C; Banfi, S; Bedoni, N; Brunetti-Pierri, N; Cappuccio, G; Corton, M; Di Rocco, M; Filocamo, M; Lanza, F; Lualdi, S; Morana, G; Nigro, V; Pinelli, M; Quinodoz, M; Rivolta, C; Simonelli, F; Superti-Furga, A; Testa, F; Torella, A | 1 |
Chandel, NS; Horbinski, CM; McElroy, GS; Mithal, DS; Reczek, CR; Reyfman, PA | 1 |
Ballarò, R; Baumann, M; Euro, L; Hentilä, J; Hulmi, JJ; Lalowski, M; Lautaoja, JH; Nissinen, TA; Penna, F; Pirinen, E; Pöllänen, N; Ritvos, O; Soliymani, R | 1 |
Jeong, H; Kim, KW; Lee, Y; Park, KH | 1 |
He, M; Hua, R; Shao, YK; Shen, QW; Wang, GZ; Wang, M; Wu, M; Yang, YP; Yao, QY; Zang, Y; Zhang, ZY | 1 |
Hwang, Y; Jang, KH; Kim, E | 1 |
Boatright, JH; Brenner, C; Chrenek, MA; Girardot, PE; Henneman, NF; Li, Y; Nickerson, JM; Sellers, JT; Wang, J; Zhang, X | 1 |
Cardoso, D; Muchir, A | 1 |
Cantón-Sandoval, J; Corbalán-Vélez, R; García-Moreno, D; Martínez-Menchón, T; Martínez-Morcillo, FJ; Mesa-Del-Castillo, P; Mulero, V; Pérez-Oliva, AB | 1 |
Brenner, C; Hatano, M; Hattori, T; Higashida, H; Hori, O; Ito, M; Noda, M; Okamoto, H; Roboon, J; Sugimoto, H; Takaso, Y; Yamamoto, Y; Yoshizaki, T | 1 |
Harigae, H; Hashizume, Y; Ito, S; Kumakura, S; Miyazaki, M; Sato, E; Sekimoto, A; Takahashi, N; Yamakage, S | 1 |
Bugarski, M; Ghazi, S; Hall, AM; Martins, JR; Polesel, M | 1 |
Aksentijević, D; Bridges, HR; Burger, N; Grba, DN; Hirst, J; James, AM; Krieg, T; Kula-Alwar, D; Mottahedin, A; Murphy, MP; Prag, HA; Viscomi, C; Yin, Z | 1 |
Brown, EE; Du, J; Farmer, R; Greenwald, SH; Hennessey, E; Pierce, EA; Scandura, MJ; Wang, Y | 1 |
Babbar, M; Bohr, VA; Croteau, DL; Dan, X; Demarest, T; Hou, Y; Kimura, R; Krishnamurthy, S; Lee, JH; Mattson, MP; McDevitt, R; Wechter, N; Yang, B; Zhang, S; Zhang, Y | 1 |
Hasegawa, K; Itoh, H; Kanda, T; Kawaguchi, T; Kusahana, E; Muraoka, H; Ono, T; Sakamaki, Y; Tokuyama, H; Wakino, S; Yasuda, I | 1 |
Blanc, J; Burkin, D; Coletti, D; Deloux, R; Karoui, A; Lavery, G; Li, Z; Mericskay, M; Mougenot, N; Tannous, C | 1 |
Chen, Z; Liang, Y; Tanzi, RE; Wang, C; Wey, HY; Xu, Y; Zhang, C | 1 |
Altamirano, F; Elnwasany, A; Gillette, TG; Hill, JA; Jiang, N; Kass, DA; Lavandero, S; Lee, DI; Schiattarella, GG; Szweda, LI; Szweda, PA; Tong, D; Verdin, E; Yoo, H | 1 |
Hosseini, L; Mahmoudi, J; Pashazadeh, F; Sadigh-Eteghad, S; Salehi-Pourmehr, H | 1 |
Alan Maschek, J; Byun, J; Huang, CY; Ikeda, Y; Imai, N; Kashihara, T; Kashyap, S; Mizushima, W; Oka, SI; Ralda, G; Sadoshima, J; Tippetts, TS; Tong, M; Venkatesh, S; Warren, JS; Xu, X; Zhai, P | 1 |
Gao, Y; He, F; He, W; Huang, X; Jian, B; Liang, Z; Min, X; Pang, J; Xiong, H; Yang, H; Ye, Y; Zhan, T; Zhang, W; Zheng, Y | 1 |
Chen, Z; Han, R; Li, M; Mao, GH; Qin, ZH; She, J; Sheng, R; Wang, F; Wang, XX; Wu, JC; Zhang, R | 1 |
Celardo, I; Fedele, G; Loh, SHY; Martins, LM; Yu, Y | 1 |
Chang, Y; Hu, Z; Ji, F; Jiang, Y; Lan, X; Li, J; Li, P; Li, S; Nie, M; Pang, H; Song, L; Song, Z; Wang, S; Wang, Y; Xiao, N; Xu, Z; Yao, K; Yao, L; Zheng, Y | 1 |
Brenner, C; Hamity, MV; Hammond, DL; Schmidt, MS; Walder, RY; White, SR | 1 |
Beggs, AH; Buj-Bello, A; Childers, MK; Elverman, M; Goddard, MA; Grange, RW; Kelly, VE; Lawlor, MW; Mack, D; Marsh, AP; Meng, H; Poulard, K; Snyder, JM | 1 |
Guan, YF; Kong, YY; Li, GQ; Miao, CY; Wang, P; Wei, CC | 1 |
Bian, H; Guo, Z; Guo, ZN; Hu, Q; Huang, JL; Manaenko, A; Tang, J; Yang, P; Zhang, JH | 1 |
Chen, S; Feun, LG; Kandemir, H; Kuo, MT; Li, YY; Nguyen, DJM; Prince, JS; Savaraj, N; Shah, S; Wangpaichitr, M; Wu, C | 1 |
Cioffi, GA; Liebmann, JM | 1 |
Abu Aboud, O; Baloglu, E; Chen, X; Chmiel, KJ; Dionne, LK; Hwang, VJ; Li, X; Mahjoub, MR; Senapedis, W; Shim, K; Trott, J; Weiss, RH; Zhou, X | 1 |
Alfano, RR; Harvey, G; Harvey, T; Lu, L; Rodríguez-Contreras, A; Shi, L | 1 |
Brown, MA; Chapman, G; Colley, A; Collins, F; Duncan, EL; Dunwoodie, SL; Enriquez, A; Giannoulatou, E; Guillemin, GJ; Halliday, J; Ho, JWK; Hughes, JN; Humphreys, DT; Ip, E; Kikuchi, K; Leo, PJ; Lim, CK; Maghzal, GJ; Mark, PR; Martin, EMMA; McInerney-Leo, AM; Moreau, J; Rapadas, M; Shi, H; Sillence, DO; Smith, J; Sparrow, DB; Stocker, R; Sugimoto, K; Szot, JO; Thomas, PQ; Wang, R; Winlaw, DS | 1 |
Athilingam, T; Sharma, RK; Singh, V; Sinha, N; Sinha, P; Thakur, AK | 1 |
Baloglu, E; Chen, Y; Chien, W; Ding, LW; Gery, S; Jiang, YY; Koeffler, HP; Lill, M; Lin, DC; Madan, V; Mayakonda, A; Müschen, M; Park, E; Senapedis, W; Sudo, M; Sun, QY; Takao, S; Xu, L | 1 |
Fang, L; Ji, Z; Liu, H; Yu, Y; Zhou, Z | 1 |
Auwerx, J; Beck, JS; Counts, SE; D'Amico, D; Mouchiroud, L; Moullan, N; Potenza, F; Rietsch, S; Romani, M; Schmid, AW; Sorrentino, V; Zhang, H | 1 |
Baczkó, I; Blanc, J; Brenner, C; Breton, M; Decaux, JF; Deloux, R; Diguet, N; Garnier, A; Gouge, A; Gressette, M; Lavery, GG; Li, Z; Manoury, B; Mericskay, M; Mougenot, N; Piquereau, J; Tannous, C; Trammell, SAJ; Zoll, J | 1 |
Calzzani, RA; Fernández, RAR; Iyomasa, DM; Iyomasa, MM; Leite-Panissi, CRA; Nascimento, GC; Pereira, YCL | 1 |
Arulkumaran, N; Courtneidge, H; Duchen, MR; Greco, E; Hall, AM; Pollen, S; Singer, M; Tam, FWK; Unwin, RJ | 1 |
Alam, SR; Hu, S; Kashatus, D; Periasamy, A; Siller, KH; Svindrych, Z; Wallrabe, H; Wang, T | 1 |
Brooks, HL; Coombes, JS; Gobe, GC; Johnson, DW; Morais, C; Roy, SF; Sanchez, WY; Small, DM | 1 |
Carruba, MO; Corsetti, G; Nisoli, E; Ragni, M; Rossi, F; Ruocco, C; Tedesco, L; Valerio, A | 1 |
Ali, A; Aon, MA; Baur, JA; Bernier, M; Bohr, VA; Brenner, C; Cortassa, S; de Cabo, R; Di Francesco, A; Elliott, PJ; Ellis, JL; Fang, EF; Frederick, DW; Kaiser, TA; Kim, EY; Mitchell, SJ; Navas-Enamorado, I; Palacios, HH; Sauve, AA; Schmidt, MS; Sinclair, DA; Waltz, TB; Zhang, N | 1 |
Boas, DA; Devor, A; Fu, B; Gómez, CA; Sakadžić, S; Sutin, J; Uhlirova, H; Wu, W; Yaseen, MA | 1 |
Abreu, AR; Campos, GV; Chianca-Jr, D; de Menezes, RC; de Noronha, SR; de Souza, AA; Lima, PM | 1 |
Krishnamurthy, S; Kumar, A; Narayan, G; Samaiya, PK | 1 |
Chen, S; Le, WD; Zhang, JJ; Zhou, QM | 1 |
Hasegawa, K; Itoh, H; Kanda, T; Kawabe, H; Kitahama, R; Komatsu, M; Kurokochi, A; Ono, T; Shigaki, S; Tokuyama, H; Urai, H; Wakino, S; Yukioka, H | 1 |
Baden, P; Bandmann, O; De Cicco, S; Deleidi, M; Di Napoli, G; Gasser, T; Giunta, I; Heimrich, B; Ivanyuk, D; Keatinge, M; Nestel, S; Panagiotakopoulou, V; Pruszak, J; Sanchez-Martinez, A; Schöndorf, DC; Schwarz, LK; Whitworth, AJ; Yu, C | 1 |
Bonne, G; Chatzifrangkeskou, M; Mericskay, M; Morales Rodriguez, B; Mougenot, N; Muchir, A; Vignier, N; Wahbi, K | 1 |
Auwerx, J; Cialabrini, L; De Franco, F; de Seigneux, S; Gariani, K; Giacchè, N; Ivanisevic, J; Katsyuba, E; Legouis, D; Liscio, P; Matilainen, O; Mottis, A; Pellicciari, R; Raffaelli, N; Ryu, D; Schoonjans, K; Stokar-Regenscheit, N; van der Velpen, V; Zietak, M | 1 |
Ajiboye, TO; Ibitoye, OB | 1 |
Ramanujan, VK | 1 |
Brewer, GJ; Digman, MA; Dong, Y | 1 |
Ariyachaokun, K; Beckham, KSH; Botella, L; Boudehen, YM; Cianci, M; Colom, A; de Carvalho, LPS; Freire, DM; Garza-Garcia, A; Genevaux, P; Grabowska, AD; Gutierrez, C; Neyrolles, O; Panikova, T; Parret, AHA; Peixoto, A; Pogenberg, V; Sala, AJ; Schnappinger, D; Schneider, TR; Svergun, DI; Tuukkanen, A; Wilmanns, M | 1 |
Fan, R; Huang, Y; Qian, X; Ruan, HB; Sun, X; Wang, Q; Xiong, X; Xu, L; Yu, J; Zhang, C | 1 |
Abell, L; Caudal, A; Lee, CF; Nagana Gowda, GA; Tian, R | 1 |
Gemeinhardt, O; Geyer, B; Klopfleisch, R; Lehmann, KS; Neizert, CA; Niehues, SM; Poch, FGM; Vahldiek, JL | 1 |
Chen, H; Du, H; Li, S; Lou, X; Ning, L; Shan, G; Sun, Z; Xu, C; Xu, G; Zhang, F | 1 |
Bae, M; Hu, S; Kang, H; Kim, MB; Lee, JY; Lee, Y; Park, YK; Pham, TX | 1 |
Gong, YL; Hou, YF; Huang, GR; Li, ST; Liu, JM; Shan, C; Sun, LH; Tao, B; Wang, SM; Zhao, HY; Zhu, Q; Zhuang, QQ | 1 |
Costa-Machado, LF; Fernandez-Marcos, PJ | 1 |
Brockman, J; Cao, T; Fan, GC; Ni, R; Peng, T; Wang, G; Zhang, L; Zhang, Y; Zheng, D; Zheng, M; Zhong, H | 1 |
Brewer, GJ; Dong, Y | 1 |
Xu, MJ; Zhang, QL; Zhang, WY | 1 |
Brewer, GJ; Digman, MA; Dong, Y; Sameni, S | 1 |
McCullough, LD; Siegel, CS | 1 |
Ghanian, Z; Maleki, S; Park, S; Ranji, M; Sheibani, N; Sorenson, CM | 1 |
Brewer, GJ; Ghosh, D; LeVault, KR | 1 |
Chi, Y; Sauve, AA | 1 |
Chuo, W; Guo, S; Han, J; Li, C; Li, D; Liu, Z; Ouyang, Y; Wang, W; Wang, Y; Wu, Y | 1 |
Arteaga, CL; Cook, RS; Hicks, DJ; Lafontant, A; Manning, HC; Skala, MC; Walsh, AJ | 1 |
Bobba, N; Calliari, A; Chini, EN; Escande, C | 1 |
Aubry, D; Breton, CS; Duchosal, MA; Majjigapu, SR; Nahimana, A; Sordat, B; Vogel, P | 1 |
Choi, JM; Kim, L; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ; Yang, SJ | 1 |
Gottlieb, RA; Mentzer, RM; Perry, CN; Wider, J | 1 |
Duffield, GE; Liangpunsakul, S; Pywell, CM; Ross, RA; Zhou, P | 1 |
Karamanlidis, G; Kuroda, J; Lee, CF; Matsushima, S; Sadoshima, J; Tian, R; Wang, W; Yu, Q | 1 |
Choi, YH; Kim, SG; Kim, TH; Shin, SY; Wu, H | 1 |
Camp, SM; Deaton, R; Gann, PH; Garcia, JG; Letsiou, E; Ma, W; Machado, RF; Messana, J; Moreno-Vinasco, L; Quijada, H; Saadat, L; Sammani, S; Siegler, J; Wang, T; Zaidi, RS | 1 |
Auwerx, J; Cerutti, R; Dantzer, F; Lamperti, C; Leoni, V; Li, W; Marchet, S; Pirinen, E; Sauve, AA; Schon, EA; Viscomi, C; Zeviani, M | 1 |
Dai, C; Ding, Z; Hu, D; Hu, X; Ji, B; Luo, Y; Pan, Q; Wu, H; Xie, J | 1 |
Arredouani, MS; Biefer, HR; Camacho, V; de la Fuente, MA; Edtinger, K; El Fatimy, R; ElKhal, A; Ghiran, I; Kissick, HT; Krenzien, F; Kuo, WP; Li, S; Quante, M; Smith, BD; Tigges, JC; Toxavidis, V; Trachtenberg, AJ; Tullius, SG; Uehara, H; Vasudevan, A; Yang, X | 1 |
Li, X; Liu, Q; Zhang, C | 1 |
Hu, SM; Liu, LX; Rebecchi, M; Wang, C; Xie, H; Zhang, J; Zhu, J | 1 |
Aksentijević, D; Brookes, PS; Chouchani, ET; Costa, ASH; Dare, AJ; Davidson, SM; Duchen, MR; Eaton, S; Eyassu, F; Frezza, C; Gaude, E; Hartley, RC; Hu, CH; James, AM; Krieg, T; Logan, A; Murphy, MP; Nadtochiy, SM; Ord, ENJ; Pell, VR; Robb, EL; Robinson, AJ; Rogatti, S; Saeb-Parsy, K; Shattock, MJ; Shirley, R; Smith, AC; Sundier, SY; Work, LM | 1 |
Borges, CM; Lopes de Faria, JB; Lopes de Faria, JM; Papadimitriou, A; Peixoto, EB; Silva, KC | 1 |
Kumar, A; Mishra, J | 1 |
Bennett, ES; Chapalamadugu, KC; Kolliputi, N; Panguluri, SK; Tipparaju, SM | 1 |
Harrington, M | 1 |
Czechowska, G; Dudka, J; Korolczuk, A; Maciejewski, M; Smolen, A; Widelska, I | 1 |
Jiang, WX; Lu, JT; Lu, YB; Tang, C; Wei, EQ; Wu, M; Zhang, WP; Zhang, XQ | 1 |
Awasthi, V; Hedrick, AF; Hussain, A; Rao, G; Xie, J; Yadav, VR | 1 |
Janíček, R; Kyrychenko, V; Poláková, E; Shirokova, N | 1 |
Biondaro Góis, M; de Almeida Araújo, EJ; de Araujo Pereira, LG; de Mello Gonçales Sant'Ana, D; Garcia, JL; Martins Moreira, N; Nogueira de Melo, Gde A; Vicentino-Vieira, SL | 1 |
Cowley, AW; Dash, RK; Ghanian, Z; Kurth, T; Ranji, M; Salehpour, F; Yang, C; Zheleznova, NN | 1 |
Assadi-Porter, FM; Bolandnazar, Z; Bütz, DE; Haviland, JA; Porter, WP; Selen, ES; Tonelli, M | 1 |
Cho, JH; Chou, JY; Jun, HS; Kim, GY; Lee, YM; Mansfield, BC; Pan, CJ; Springer, DA | 1 |
Bejaoui, M; Folch-Puy, E; Palmeira, CM; Panisello, A; Pantazi, E; Pinto Rolo, A; Roselló-Catafau, J; Zaouali, MA | 1 |
Awasthi, V; Hedrick, A; Rao, G; Xie, J | 1 |
Dao, TH; Echlin, H; Johnson, MD; Rosch, JW | 1 |
Cho, EY; Choe, SK; Khadka, D; Kim, HJ; Kwak, TH; Lee, S; Lee, SB; Oh, GS; Pandit, A; Park, R; Shen, A; Shim, H; So, HS; Yang, SH | 1 |
Auwerx, J; Cantó, C; Fomitchova, A; Gariani, K; Kim, B; Koo, SI; Ku, CS; Lee, JY; Lemos, V; Menzies, KJ; Moullan, N; Park, YK; Perino, A; Pham, TX; Piersigilli, A; Ropelle, ER; Ryu, D; Sauve, AA; Schoonjans, K; Wang, X; Wegner, CJ; Yang, Y; Zhang, H | 1 |
Bramlett, HM; Brand, FJ; de Rivero Vaccari, JP; Patel, HH; Perez-Pinzon, MA; Raval, AP | 1 |
He, F; Luo, B; Peng, G; Song, X; Wang, J; Wei, R; Xu, Y | 1 |
Shibata, K | 1 |
Amaral, AU; de Souza, DO; Goodman, SI; Leipnitz, G; Rodrigues, MD; Seminotti, B; Wajner, M; Woontner, M | 1 |
Albini, A; Bertolini, F; Calleri, A; Dallaglio, K; Gregato, G; Labanca, V; Mancuso, P; Noonan, DM; Orecchioni, S; Reggiani, F; Rossi, T; Talarico, G | 1 |
Chen, L; Chen, W; Elrami, F; Ge, X; Kitten, T; Kong, F; Xu, P; Yu, Y; Zhang, M | 1 |
Ai, ML; Ai, YH; Ma, XH; Peng, QY; Zhang, LN; Zou, Y | 1 |
Celardo, I; Costa, AC; Lehmann, S; Loh, SH; Martins, LM | 1 |
Batchelor, TT; Cahill, DP; Chi, AS; Curry, WT; Flaherty, KT; Ho, Q; Iafrate, AJ; Lelic, N; Onozato, ML; Sundaram, S; Tateishi, K; Wakimoto, H | 1 |
Aebersold, R; Auwerx, J; D'Amico, D; Gariani, K; Luan, P; Lutolf, MP; Menzies, KJ; Ropelle, ER; Ryu, D; Schoonjans, K; Wang, X; Wu, Y; Zhang, H | 1 |
Hu, X; Sakurai, T; Takata, T; Wang, X; Yang, Y | 1 |
Bragin, DE; Nemoto, EM; Statom, G | 1 |
Ido, Y | 1 |
Guan, YF; Miao, CY; Wang, P; Wang, SN; Wang, X; Xu, TY; Zhang, SL | 1 |
Fu, H; Huang, F; Li, DJ; Ni, M; Shen, FM; Zhang, LS | 1 |
Abu Aboud, O; Argueta, C; Baloglu, E; Chen, CH; Senapedis, W; Weiss, RH | 1 |
de Vries, HJ; Niessen, HW; Rodenburg, RJ; Stienen, GJ; Wintjes, LT; Wüst, RC | 1 |
Kristian, T; Long, A; Owens, K; Park, JH | 1 |
Bragin, DE; Bragina, OA; Kameneva, MV; Nemoto, EM; Peng, Z; Statom, GL | 1 |
Correani, V; d'Erme, M; Fontana, M; Forte, E; Fuso, A; Maras, B; Martire, S; Mosca, L; Scarpa, S | 1 |
Chan, SH; Chen, SD; Chuang, YC; Huang, CW; Lin, JW; Lin, TK; Liou, CW; Zhen, YY | 1 |
Bramley, JC; Buchser, WJ; Clark, KB; Collins, SV | 1 |
Calvo-Silva, FJ; Fernández-Valverde, F; García-Morales, J; Orozco-Ibarra, M; Serrano-García, N | 1 |
Golovine, K; Ji, Y; Kolenko, V; Kotova, E; Lodhi, N; Makhov, P; Pechenkina, K; Pinnola, AD; Thomas, C; Tulin, AV | 1 |
Bohr, VA; Bollineni, RC; Croteau, DL; Fang, EF; Iser, WB; Kalyanasundaram, S; Kassahun, H; Kerr, JS; Li, J; Lu, H; Lu, Q; Marosi, K; Mattson, MP; Morevati, M; Nilsen, H; Scheibye-Knudsen, M; Shamanna, RA; Sinclair, DA; Tian, J; Waltz, TB; Wilson, MA; Wollman, BN | 1 |
Agarwal, B; Baur, JA; Chellappa, K; Davis, JG; Dellinger, RW; Moffitt, A; Mukherjee, S; Ndungu, J | 1 |
Jia, L; Li, J; Li, W; Li, Y; Lu, X; Luan, Y; Ma, L; Qi, H; Song, H; Yang, Y | 1 |
Barneveld, AV; Dethlefsen, S; Munder, A; Okon, E; Pelnikevich, A; Tümmler, B | 1 |
Deshpande, DA; Guedes, AGP; Kannan, MS; Lund, FE; Subramanian, S; Walseth, TF | 1 |
Auwerx, J; Bai, P; Boulares, AH; Cao, Z; Gao, B; Gariani, K; Godlewski, G; Haskó, G; Holovac, E; Horváth, B; Liaudet, L; Mukhopadhyay, P; Nemeth, BT; Pacher, P; Paloczi, J; Park, O; Persidsky, Y; Rajesh, M; Ryu, D; Varga, ZV; Wang, W; Xu, MJ; Zhou, Z | 1 |
Date, I; Haruma, J; Hiramatsu, M; Hishikawa, T; Kawase, H; Mizoue, R; Morimatsu, H; Nishihiro, S; Sato, S; Shimizu, T; Shinji, Y; Sugiu, K; Takasugi, Y; Takeda, Y | 1 |
Hershberger, KA; Hirschey, MD; Martin, AS | 1 |
Adiels, M; Barrett, PH; Bjornson, E; Boren, J; Hakkarainen, A; Hallström, BM; Kilicarslan, M; Klevstig, M; Lundbom, J; Lundbom, N; Mardinoglu, A; Marschall, HU; Nielsen, J; Serlie, MJ; Smith, U; Söderlund, S; Ståhlman, M; Taskinen, MR; Uhlén, M; Vergès, B; Watts, GF; Zhang, C | 1 |
Cooper, ME; Coughlan, MT; Forbes, JM | 1 |
Demos, SG; Matthews, DL; Pivetti, CD; Raman, RN; Troppmann, C | 1 |
Liu, T; O'Rourke, B | 1 |
Abdin, AA; Hamouda, HE | 1 |
Arai, M; Morita, K; Sasaki, T; Shiraishi, K; Takeda, Y; Taninishi, H | 1 |
Barbiro-Michaely, E; Mayevsky, A; Simonovich, M | 1 |
Barbiro-Michaely, E; Luger-Hamer, M; Mayevsky, A; Sonn, J | 1 |
Choi, HS; Chung, J; Han, J; Hwang, JH; Jang, C; Jo, EJ; Jo, YS; Kho, YL; Kim, DW; Kim, JM; Kim, YK; Kwak, TH; Kweon, GR; Kyung, T; Lee, I; Lee, SH; Park, JH; Park, MK; Shong, M; Yoo, SK | 1 |
Chan, SH; Chang, AY; Chang, WN; Chen, SD; Chuang, YC; Lin, TK; Liou, CW | 1 |
Decoster, B; Favory, R; Hassoun, SM; Lancel, S; Motterlini, R; Neviere, R | 1 |
Almendares, A; Giulivi, C; Ross-Inta, CM; Zhang, YF | 1 |
Chance, B; Gorman Iii, JH; Gorman, RC; Hinmon, RH; Jaggard, DL; Leshnower, BG; Matsubara, M; Ranji, M | 1 |
Manaenko, A; Sozen, T; Tang, J; Tsuchiyama, R; Zhang, JH | 1 |
Bertelli, M; Cerboni, B; Di Marcello, F; Jacomelli, G; Jinnah, HA; Micheli, V; Notarantonio, L; Pompucci, G; Sestini, S | 1 |
Chaudhary, N; Pfluger, PT | 1 |
Fujino, H; Hayashi, Y; Kitaoka, Y; Kumai, T; Lam, TT; Munemasa, Y; Sadun, AA; Takeda, H; Ueno, S | 1 |
Hariharan, N; Hsu, CP; Oka, S; Sadoshima, J; Shao, D | 1 |
Fujie, H; Koike, K; Matsuura, Y; Miyamura, T; Miyoshi, H; Moriishi, K; Moriya, K; Shintani, Y; Shinzawa, S; Suzuki, T; Tsutsumi, T; Yotsuyanagi, H | 1 |
Barbiro-Michaely, E; Livnat, A; Mayevsky, A | 1 |
Azarbayjani, F; Christofferson, R; Eriksson, S; Fuchs, D; Rodriguez, A; Sundberg, C | 1 |
Chen, B; Jacobs, WR; Vilchèze, C; Weinrick, B; Wong, KW | 1 |
Kanwar, YS; Oates, PJ; Srivastava, SK; Sun, L; Xie, P | 1 |
Aponte, A; Deschamps, A; Lagranha, CJ; Murphy, E; Steenbergen, C | 1 |
Breedlove, SM; Johansen, JA; Jordan, CL; Lieberman, AP; Mo, K; Monks, DA; Troxell-Smith, SM; Yu, Z | 1 |
Brookes, PS; Nadtochiy, SM; Rahman, I; Redman, E | 1 |
Bellac, CL; Christen, S; Coimbra, RS; Leib, SL | 1 |
Desir, GV; Flavell, RA; Giordano, F; Li, G; Liu, D; Pestana, M; Quelhas-Santos, J; Russell, K; Russell, R; Sampaio-Maia, B; Velazquez, H; Wang, P; Wu, Y; Xu, J | 1 |
Choi, WS; Palmiter, RD; Xia, Z | 1 |
Gu, Y; Sun, M; Xu, C; Zhao, Y | 1 |
Acuña-Castroviejo, D; Camacho, E; Carrión, MD; Doerrier, C; Escames, G; Espinosa, A; López, LC; Mora, F; Tapias, V | 1 |
Andreu, AL; Ferrer, I; Fourcade, S; Galino, J; García-Arumí, E; Guilera, C; Jove, M; López-Erauskin, J; Naudi, A; Pamplona, R; Portero-Otin, M; Pujol, A; Ruiz, M; Schlüter, A; Starkov, AA | 1 |
Gang, GT; Hwang, JH; Kim, DH; Kim, YH; Kwak, TH; Lee, CH; Lee, IK; Noh, JR; Shong, M; Son, HY | 1 |
Barkhouse, DA; Castegna, A; Curtis, MT; Fabis-Pedrini, MJ; Hooper, DC; Kean, RB; Palmieri, F; Palmieri, L; Porcelli, V; Spera, I | 1 |
Agarwal, S; Joshi, S; Mayevsky, A; Wang, M | 1 |
Abeti, R; Abramov, AY; Duchen, MR | 1 |
Adachi, T; Amo, T; Fukuda, K; Ishiwata, K; Katsumata, Y; Nakashima-Kamimura, N; Ohta, S; Sano, M; Shinmura, K; Suematsu, M; Tamaki, K; Wolf, AM | 1 |
Amorini, AM; Barrios, L; Di Pietro, V; Marmarou, A; Marmarou, CR; Pascual, JM; Prieto, R; Tavazzi, B; Taya, K | 1 |
Imai, S; Mills, KF; Yoon, MJ; Yoshino, J | 1 |
Day, BJ; Huang, TT; Liang, LP; Patel, M; Rowley, S; Waldbaum, S | 1 |
Han, J; Liu, J; Shi, S; Xia, W; Ying, W; Zheng, C | 1 |
Fernandez, E; Goldstein, DS; Martinez, PA; Strong, R; Sullivan, P; Wey, MC | 1 |
Barnett, AJ; Brewer, GJ; Ghosh, D; LeVault, KR | 1 |
Cai, AL; Sheline, CT; Shi, C; Zhang, W; Zhu, J | 1 |
Fukuoka, S; Fukuwatari, T; Nakao, N; Sano, M; Sasaki, R; Shibata, K; Terakata, M | 1 |
Crawford, BD; Goody, MF; Henry, CA; Kelly, MW; Khalil, A; Reynolds, CJ | 1 |
Fukuda, D; Hirata, Y; Kurobe, H; Maeda, N; Masuzaki, H; Sakaue, H; Sata, M; Sato, H; Shimabukuro, M; Shimomura, I; Shiota, A; Soeki, T; Uematsu, E | 1 |
Guptill, V; Kenyon, N; Khaibullina, A; Koziol, D; Moya, PR; Mukherjee, AB; Quezado, MM; Quezado, ZM; Saha, A; Wang, L; Wesley, R; Zhang, Z | 1 |
Barbiro-Michaely, E; Mayevsky, A | 1 |
Bai, S; Sheline, CT | 1 |
Bai, S; Sheline, CR; Sheline, CT; Zhou, Y | 1 |
Eells, J; Ghanian, Z; Gopalakrishnan, S; Maleki, S; Ranji, M; Schmitt, H; Sepehr, R | 1 |
Buchheim, K; Gabriel, S; Heinemann, U; Kann, O; Kovacs, R; Schuchmann, S | 1 |
Büchner, M; Huber, R; Riepe, MW; Staufenbiel, M; Sturchler-Pierrat, C | 1 |
Clark, RS; Dixon, CE; Jenkins, LW; Kochanek, PM; Melick, J; Satchell, MA; Szabó, C; Zhang, X | 1 |
Christen, S; Ghielmetti, M; Leib, SL; Ren, H; Täuber, MG | 1 |
Bartleman, AP; Boyonoski, AC; Kirkland, JB; Spronck, JC | 1 |
Adams, JD; Chang, ML; Kem, S; Klaidman, L; Morales, M; Yang, J | 1 |
Begum, L; Horiuchi, M; Iijima, M; Jalil, MA; Kobayashi, K; Li, MX; Moriyama, M; Robinson, BH; Saheki, T; Sinasac, DS; Tsui, LC | 1 |
Cosi, C; Fluit, P; Gallo-Hendrikx, E; Marien, MR; Martel, JC; Mount, HT; Wu, Y | 1 |
Jeong, HY; Kim, CD | 1 |
Koh, JY; Lee, JY; Lee, SE; Yoo, MH; Yoon, YH | 1 |
Mayevsky, A; Meilin, S; Mendelman, A; Zarchin, N | 1 |
Barbiro-Michaely, E; Mayevsky, A; Salame, K; Simonovich, M | 1 |
Komeda, M; Miwa, S; Nishimura, K; Tanaka, S; Toyokuni, S; Ueda, K; Unimonh, O; Yamazaki, K | 1 |
French, BA; French, SW; Fu, P; Li, J | 1 |
Barbiro-Michaely, E; Hadani, M; Knoller, N; Mayevsky, A | 1 |
Dziewulska, J; Jesko, H; Strosznajder, RP | 1 |
Baeza, I; Chena, MA; Elizondo, S; Nogueda, B; Rodríguez-Páez, L; Wong, C | 1 |
Mayevsky, A; Sonn, J | 1 |
Jainu, M; Prabhu, S; Sabitha, KE; Shyamala Devi, CS | 1 |
Kaundal, RK; Shah, KK; Sharma, SS | 1 |
Lu, H; Shi, J; Tang, X; Wang, D; Wang, Q; Wei, G; Ying, W; Zhang, P | 1 |
Bellen, HJ; Cao, Y; Hiesinger, PR; Mehta, SQ; Schulze, KL; Verstreken, P; Zhai, RG; Zhou, Y | 1 |
Buttrick, PM; Lewandowski, ED; O'donnell, JM; Scholz, TD; Sorokina, N | 1 |
Chávez, E; Correa, F; Franco, M; García, N; Martínez-Abundis, E; Santamaría, J; Zazueta, C | 1 |
Intaglietta, M; Johnson, PC; Pal, M; Tóth, A | 1 |
Kirkland, JB; Thorn, SL; Young, GS | 1 |
Cheng, R; Hart, AC; Stockwell, BR; Varma, H; Voisine, C | 1 |
Hatai, A; Kato, J; Kurasaki, M; Mukai, Y; Sagai, M; Sato, S; Yamate, J | 1 |
Arutunyan, A; Kay, M; Martell, B; Sarvazyan, N; Swift, L | 1 |
Cabrales, P; Intaglietta, M; Salazar Vázquez, BY; Tsai, AG; Wettstein, R | 1 |
Lai, JC; Leung, TK; Lim, L | 1 |
Auscher, C; Brouilhet, H; Rabaud, M; Van der Kemp, P | 1 |
Gil'miiarova, FN; Radomskaia, VM; Vinogradova, LN | 1 |
Avontuur, JA; Bruining, HA; Coremans, JM; Ince, C; Sinaasappel, M; van der Sluijs, JP | 1 |
ApSimon, MM; Kirkland, JB; Rawling, JM | 1 |
Konno, K; Nagai, A; Ozawa, Y; Uno, H; Yasui, S | 1 |
Anderson, RE; Meyer, FB; Tomlinson, FH | 1 |
Mayevsky, A; Osbakken, M | 1 |
Bernocchi, P; Ceconi, C; Curello, S; Ferrari, R; Pasini, E; Pedersini, P | 1 |
Adachi, T; Aikawa, N; Hori, S; Inoue, S; Miyazaki, K; Nakagawa, M; Nakazawa, H; Ogawa, S; Ohnishi, Y | 1 |
Caputi, AP; Cuzzocrea, S; Zingarelli, B | 1 |
Bers, DM; Brandes, R; Maier, LS | 1 |
Rosser, DM; Singer, M; Stidwill, RP | 1 |
Caputi, AP; Costantino, G; Cuzzocrea, S | 1 |
Kaleysa Raj, R; Sivan, VM | 1 |
Burkart, V; Heller, B; Herceg, Z; Kolb, H; Radons, J; Stingl, L; Wagner, EF; Wang, ZQ | 1 |
Borgerding, AJ; Carlson, EC; Epstein, PN; Liang, Q | 1 |
Caputi, AP; Costantino, G; Cuzzocrea, S; De Sarro, A; Mazzon, E | 1 |
Bruining, HA; Coremans, JM; Naus, DC; Puppels, GJ; Van Aken, M; Van Velthuysen, ML | 1 |
Chen, D; Chen, J; Henshall, DC; Nagayama, T; Pei, W; Simon, RP; Stetler, RA | 1 |
Mies, G; Oláh, L; Paschen, W | 1 |
Abe, S; Ban, K; Handa, S; Hattan, N; Hori, S; Iida, A; Kawada, S; Mohammed, MU; Mori, H; Nakazawa, H; Onishi, Y; Sato, E; Sekka, T; Shinozai, Y; Sugio, Y; Suma, H; Tanaka, E | 1 |
Dabbeni-Sala, F; Franceschini, D; Giusti, P; Skaper, SD | 1 |
Surolia, A; Surolia, N | 1 |
Caputi, AP; Cuzzocrea, S; De Sarro, A; Dugo, L; Fulia, F; Serraino, I | 1 |
Barbiro-Micahely, E; Mayevsky, A | 1 |
Herbert, M; Kemmer, G; Kraiss, A; Reidl, J; Schlör, S; Schmidt-Brauns, J | 1 |
Caputi, AP; Cuzzocrea, S; Dugo, L; Mazzon, E; McDonald, MC; Serraino, I; Thiemermann, C; Threadgill, M | 1 |
He, XY; Lin, D; Mehta, P; Merz, G; Schulz, H; Wen, GY; Yang, SY; Yang, YZ | 1 |
August, M; Bodenschatz, M; Förstermann, U; Griendling, K; Kleschyov, AL; Lassègue, B; Li, H; Meinertz, T; Mollnau, H; Münzel, T; Oelze, M; Schulz, E; Szöcs, K; Tsilimingas, N; Walter, U; Wendt, M | 1 |
Arieff, AI; Kerian, A | 1 |
Cherniack, NS; Ginsberg, M; Goldberg, HI; Greenberg, J; Reivich, M; Slater, R; Tuteur, PG | 1 |
Baue, AE; Chaudry, IH; Sayeed, MM; Zweig, S | 1 |
Kiprov, D; Orbetzova, VT; Puchlev, A | 1 |
Briones, E; Calva, E; López-Soriano, F; Marsch, M; Núñez, R | 1 |
Benavides, J; Gimenez, C; Mayor, F; Sanchez-Rubiales, M; Valdivieso, F | 1 |
Ben-Bassat, S; Duvdevani, R; Lavie, V; Schwartz, M; Yoles, E; Zalish, M | 1 |
Breuer, Z; Mayevsky, A | 1 |
Angus, PW; Collins, JE; Dixon, RM; Kalderon, B; Leonard, JV; Oberhaensli, RD; Radda, GK; Rajagopalan, B | 1 |
Ackerman, JJ; Chen, RD; Hotchkiss, RS; Karl, IE; Lowry, OH; Manchester, JK; Neil, JJ; Song, SK | 1 |
Chumakov, VN; Starchik, TG | 1 |
Hashi, K; Kurokawa, Y; Okuyama, T; Uede, T | 1 |
Okada, Y; Shima, T; Takeda, T; Uozumi, T; Yamane, K | 1 |
Kliegman, RM | 1 |
Clark, JB; Cooper, JM; Hayes, DJ; Morgan-Hughes, JA; Petty, RK | 1 |
Rajacic, Z; Thölen, H; Zimmerli, W | 1 |
Heiss, WD; Paschen, W; Pawlik, G; Sato, M; Umbach, C | 1 |
Angrist, A; Bajusz, E; Chen, C; Nakao, K; Oka, M | 1 |
Layberry, RA; Nadkarni, BB; Paterson, RA | 1 |
Cohn, RM; Segal, S | 1 |
Holmin, T; Siesjö, BK; Vang, J | 1 |
Barak, AJ; Sorrell, MF; Tuma, DJ | 1 |
Chance, B; Mayevsky, A; Zeuthen, T | 1 |
Estler, CJ | 1 |
Anderson, T; Cooney, DA; McMenamin, MG; Schein, PS | 1 |
Kirsch, WM; Schulz, DW | 1 |
MacMillan, V | 1 |
19 review(s) available for nad and Disease Models, Animal
Article | Year |
---|---|
Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Disease Management; Disease Models, Animal; Disease Susceptibility; Doxorubicin; Humans; Metabolic Networks and Pathways; NAD; Niacinamide; Oxidative Stress; Pyridinium Compounds; Signal Transduction; Sirtuins | 2021 |
Balancing NAD
Topics: Animals; Disease Models, Animal; Mice; NAD; Niacinamide; Pyridinium Compounds | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy.
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Dystroglycans; Glycosylation; Glycosyltransferases; Humans; Muscle Development; Muscular Dystrophy, Animal; Mutation; NAD; Neuromuscular Junction; Paxillin; Up-Regulation; Zebrafish; Zebrafish Proteins | 2019 |
Programmed axon degeneration: from mouse to mechanism to medicine.
Topics: Animals; Armadillo Domain Proteins; Cytoskeletal Proteins; Disease Models, Animal; Drosophila melanogaster; Humans; Mice; Mice, Transgenic; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Signal Transduction; Translational Research, Biomedical; Wallerian Degeneration | 2020 |
Effects of NAD
Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; NAD; Nerve Regeneration; Neurodegenerative Diseases; Neuroprotection; Neurotoxins; Signal Transduction | 2020 |
Need for NAD
Topics: Animals; Disease Models, Animal; Humans; Lamin Type A; Laminopathies; Muscle, Skeletal; Muscle, Striated; Muscular Diseases; Muscular Dystrophy, Emery-Dreifuss; NAD; Nuclear Lamina | 2020 |
Non-canonical roles of NAMPT and PARP in inflammation.
Topics: Animals; Chronic Disease; Disease Models, Animal; Humans; Inflammation; NAD; Nicotinamide Phosphoribosyltransferase; Parthanatos; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Signal Transduction | 2021 |
Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Apoptosis; Behavior, Animal; Disease Models, Animal; Drug Evaluation, Preclinical; Energy Metabolism; Mice; Mice, Transgenic; Mitochondria; NAD; Neuroinflammatory Diseases; Neuroprotective Agents; Niacin; Niacinamide; Oxidative Stress; Protein Aggregation, Pathological; Rats; Synapses; tau Proteins | 2021 |
Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection.
Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Energy Metabolism; Humans; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Mitochondrial Turnover; Muscle, Skeletal; NAD; Neuroprotective Agents; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Pyridinium Compounds | 2013 |
Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3.
Topics: Aging; AMP-Activated Protein Kinases; Animals; C-Peptide; Diabetes Complications; Diabetic Angiopathies; Disease Models, Animal; Epigenesis, Genetic; Feedback, Physiological; Forkhead Box Protein O3; Humans; Hypoxia; Insulin Resistance; NAD; Oxidation-Reduction; Oxidative Stress; Signal Transduction; Sirtuin 1 | 2016 |
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
Topics: ADP-ribosyl Cyclase 1; Animals; Asthma; Calcium; Calcium Signaling; Disease Models, Animal; Gene Expression Regulation; Humans; Inflammation; Mice; MicroRNAs; Myocytes, Smooth Muscle; NAD; NADP; Respiratory Hypersensitivity | 2017 |
Role of NAD
Topics: Animals; Disease Models, Animal; Heart; Heart Diseases; Humans; Kidney; Kidney Diseases; Mitochondria; NAD; Oxidation-Reduction; Signal Transduction; Sirtuins | 2017 |
Oxidative stress as a major culprit in kidney disease in diabetes.
Topics: Animals; Cytosol; Diabetic Nephropathies; Disease Models, Animal; Energy Metabolism; Glucose; Glucosephosphate Dehydrogenase; Glycation End Products, Advanced; Glycolysis; Humans; Mitochondria; NAD; Oxidation-Reduction; Oxidative Phosphorylation; Oxidative Stress; Reactive Oxygen Species; Sorbitol | 2008 |
Metabolic benefits from Sirt1 and Sirt1 activators.
Topics: AMP-Activated Protein Kinases; Animals; Caloric Restriction; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Energy Metabolism; Humans; Mice; Mice, Transgenic; NAD; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Trans-Activators; Transcription, Genetic | 2009 |
Shedding light on mitochondrial function by real time monitoring of NADH fluorescence: II: human studies.
Topics: Animals; Brain; Carbon Dioxide; Disease Models, Animal; Equipment Design; Fluorescent Dyes; Heart; Humans; Mitochondria; Monitoring, Physiologic; Muscle, Skeletal; NAD; Neoplasms; Organ Transplantation; Oxidation-Reduction; Oxygen; Spectrometry, Fluorescence | 2013 |
Cell death and metabolic activity during epileptiform discharges and status epilepticus in the hippocampus.
Topics: Animals; Calcium Signaling; Cell Death; Disease Models, Animal; Hippocampus; NAD; NADP; Seizures; Status Epilepticus | 2002 |
Galactose metabolism and its regulation.
Topics: Animals; Carbon Dioxide; Carbon Isotopes; Chickens; Disease Models, Animal; Erythrocytes; Galactose; Galactosemias; Humans; Isomerases; Liver; NAD; Phosphotransferases; Racial Groups; Uracil Nucleotides | 1973 |
Relationship of ethanol to choline metabolism in the liver: a review.
Topics: Alcohol Oxidoreductases; Animals; Carbon Radioisotopes; Choline; Choline Deficiency; Disease Models, Animal; Ethanol; Guinea Pigs; In Vitro Techniques; Liver; NAD; Nutritional Requirements; Oxidation-Reduction; Perfusion; Propanolamines; Pyrazoles; Rats; Structure-Activity Relationship | 1973 |
2 trial(s) available for nad and Disease Models, Animal
Article | Year |
---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.
Topics: ADP-ribosyl Cyclase 1; Animals; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Female; Humans; Male; Membrane Glycoproteins; Mice; NAD; Proteomics; Signal Transduction | 2019 |
294 other study(ies) available for nad and Disease Models, Animal
Article | Year |
---|---|
A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD
Topics: Alcoholism; Animals; Disease Models, Animal; Disease Progression; Ethanol; Fatty Liver; Hepatitis, Alcoholic; Humans; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; NAD; Oxidative Stress; Sirtuin 1 | 2022 |
Multi-Systemic Alterations by Chronic Exposure to a Low Dose of Bisphenol A in Drinking Water: Effects on Inflammation and NAD
Topics: Adipose Tissue; Animals; Benzhydryl Compounds; Disease Models, Animal; Drinking Water; Environmental Exposure; Female; Health Impact Assessment; Immunohistochemistry; Inflammation; Lactation; Liver; NAD; Oxidative Stress; Phenols; Pregnancy; Rats; Sirtuin 1; Water Pollutants, Chemical; Weaning | 2021 |
Exogenous Nicotinamide Adenine Dinucleotide Attenuates Postresuscitation Myocardial and Neurologic Dysfunction in a Rat Model of Cardiac Arrest.
Topics: Animals; Disease Models, Animal; Heart Arrest; Heart Failure; NAD; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Resuscitation | 2022 |
NAMPT reduction-induced NAD
Topics: Animals; Cytokines; Diet, High-Fat; Disease Models, Animal; Embryonic Development; Female; Gene Knockdown Techniques; Meiosis; Mice; Mice, Inbred ICR; NAD; Niacin; Nicotinamide Phosphoribosyltransferase; Obesity, Maternal; Oocytes; Oxidative Stress; Pregnancy; Signal Transduction; Treatment Outcome | 2021 |
Comparative Study of Functional Changes in Heart Mitochondria in Two Modes of Epinephrine Exposure Modeling Myocardial Injury in Rats.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiomyopathies; Cations, Divalent; Disease Models, Animal; Electron Transport Complex II; Epinephrine; Glutamic Acid; Malates; Male; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; NAD; Oxidative Phosphorylation; Rats; Rats, Wistar; Succinic Acid | 2021 |
NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.
Topics: Animals; Apoptosis Inducing Factor; Cell Nucleus; Cell Proliferation; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Inflammation; Keratinocytes; Larva; NAD; NADPH Oxidases; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Parthanatos; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proteinase Inhibitory Proteins, Secretory; Psoriasis; Reactive Oxygen Species; Skin; Zebrafish; Zebrafish Proteins | 2021 |
Modulation of Cellular NAD
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Extracellular Traps; Female; Mice; Mice, Inbred BALB C; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Sirtuin 1; Thrombophilia; Thromboplastin; Thrombosis | 2021 |
NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K/Akt/mTOR signaling pathway.
Topics: Animals; Autophagy; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; NAD; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirtuin 1; Thymus Gland; TOR Serine-Threonine Kinases | 2021 |
Topics: Animals; Cell Respiration; Disease Models, Animal; Immune Evasion; Listeria monocytogenes; Listeriosis; Mice; NAD | 2022 |
Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy.
Topics: Animals; Cell Line; Cytokines; Disease Models, Animal; Mice; NAD; Neuroprotective Agents; Nicotinamide Phosphoribosyltransferase | 2022 |
Nicotinamide riboside relieves the severity of experimental necrotizing enterocolitis by regulating endothelial function via eNOS deacetylation.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Enterocolitis, Necrotizing; Mice; Microcirculation; NAD; Niacinamide; Nitric Oxide Synthase Type III; Pyridinium Compounds; Sirtuin 1; Tumor Necrosis Factor-alpha | 2022 |
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.
Topics: Animals; Cytokines; Disease Models, Animal; Mice; NAD; Nicotinamide Phosphoribosyltransferase | 2022 |
Crocin ameliorates depressive-like behaviors induced by chronic restraint stress via the NAMPT-NAD
Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Carotenoids; Depression; Disease Models, Animal; Mice; NAD; Nicotinamide Phosphoribosyltransferase; Serotonin; Sirtuin 1; Stress, Psychological; Sucrose | 2022 |
Mouse models of NADK2 deficiency analyzed for metabolic and gene expression changes to elucidate pathophysiology.
Topics: Animals; Disease Models, Animal; Gene Expression; Group VI Phospholipases A2; Humans; Hyperlysinemias; Mice; Mitochondrial Proteins; NAD; Neuroaxonal Dystrophies; Phosphotransferases (Alcohol Group Acceptor) | 2022 |
Targeting CD38 to Suppress Osteoarthritis Development and Associated Pain After Joint Injury in Mice.
Topics: Animals; Calcitonin Gene-Related Peptide; Cartilage, Articular; Disease Models, Animal; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Osteoarthritis, Knee; Pain | 2023 |
Ameliorative effect of the probiotic peptide against benzo(α)pyrene-induced inflammatory damages in enterocytes.
Topics: Animals; Benzo(a)pyrene; Caco-2 Cells; Cytokines; Disease Models, Animal; Enterocytes; Heme Oxygenase-1; Humans; Mice; NAD; NF-E2-Related Factor 2; Peptides, Cyclic; Probiotics; Quinones; Reactive Oxygen Species; Receptors, Aryl Hydrocarbon | 2022 |
Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway.
Topics: Animals; Biological Factors; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Melatonin; Mice; Mice, Inbred C57BL; Multiple Sclerosis; NAD; Nicotinamide N-Methyltransferase; Receptors, Aryl Hydrocarbon; RNA, Messenger; Severity of Illness Index; Tryptophan | 2022 |
Swim Training Affects on Muscle Lactate Metabolism, Nicotinamide Adenine Dinucleotides Concentration, and the Activity of NADH Shuttle Enzymes in a Mouse Model of Amyotrophic Lateral Sclerosis.
Topics: Adenine; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Lactic Acid; Malate Dehydrogenase; Mice; Monocarboxylic Acid Transporters; Muscle, Skeletal; NAD; Niacinamide | 2022 |
Drag-Reducing Polymers Improve Vascular Hemodynamics and Tissue Oxygen Supply in Mouse Model of Diabetes Mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Hemodynamics; Hypercapnia; Hyperglycemia; Mice; Mice, Inbred C57BL; Microcirculation; NAD; Oxygen; Polymers; Rats | 2022 |
Haemorheologic Enhancement of Cerebral Perfusion Improves Oxygen Supply and Reduces Aβ Plaques Deposition in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Hypoxia; Mice; Mice, Transgenic; NAD; Oxygen; Perfusion; Plaque, Amyloid; Polymers | 2022 |
Base-Exchange Enabling the Visualization of SARM1 Activities in Sciatic Nerve-Injured Mice.
Topics: Animals; Armadillo Domain Proteins; Axons; Cytoskeletal Proteins; Disease Models, Animal; Humans; Mice; NAD; Sciatic Nerve | 2023 |
NAD
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dietary Supplements; Disease Models, Animal; Epithelial-Mesenchymal Transition; Heterografts; Humans; Mice; NAD; Neoplasm Metastasis; Sirtuin 1; Src Homology 2 Domain-Containing, Transforming Protein 1; Triple Negative Breast Neoplasms | 2023 |
Nicotinamide restores tissue NAD+ and improves survival in rodent models of cardiac arrest.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Heart Arrest; Lactic Acid; Mice; Myocytes, Cardiac; NAD; Niacinamide; Rats; Rodentia | 2023 |
Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition.
Topics: Animals; Arginase; Cellular Senescence; Disease Models, Animal; Macrophages; Mice; NAD; Phenotype | 2023 |
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; DNA Damage; Gene Knockout Techniques; Genetic Predisposition to Disease; Glucose Intolerance; Hepatocytes; Insulin Resistance; Lipid Metabolism; Liver; Liver Diseases; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Protective Agents; Pyridinium Compounds | 2019 |
Nicotinamide phosphoribosyltransferase‑related signaling pathway in early Alzheimer's disease mouse models.
Topics: Acrylamides; Alzheimer Disease; Amyloid; Animals; Behavior, Animal; Cytokines; Disease Models, Animal; Hippocampus; Learning; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Nicotinamide Phosphoribosyltransferase; Piperidines; Signal Transduction; Sirtuin 1 | 2019 |
Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Calcium Chloride; Cells, Cultured; Dilatation, Pathologic; Disease Models, Animal; Male; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacin; Niacinamide; Receptors, G-Protein-Coupled; Receptors, LDL; Signal Transduction; Sirtuin 1 | 2020 |
NAD
Topics: Aging, Premature; Animals; Autophagy-Related Protein-1 Homolog; Caenorhabditis elegans; Cation Transport Proteins; Disease Models, Animal; Drosophila melanogaster; Humans; Intracellular Signaling Peptides and Proteins; Mitophagy; Mutation; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Werner Syndrome; Werner Syndrome Helicase | 2019 |
Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis.
Topics: Adenosine Diphosphate Ribose; ADP-ribosyl Cyclase 1; Animals; Autophagosomes; Calcium; Carbon Monoxide; Cell Line; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; NADP; Ras Homolog Enriched in Brain Protein; RNA, Small Interfering; Sepsis; Sirtuin 1; TOR Serine-Threonine Kinases; Tristetraprolin | 2020 |
Evaluation of the NAD
Topics: Amyotrophic Lateral Sclerosis; Animals; Biosynthetic Pathways; Cells, Cultured; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Motor Neurons; NAD; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Sirtuin 3; Sirtuins; Spinal Cord; Superoxide Dismutase-1 | 2020 |
The potential of the novel NAD
Topics: Adenosine Triphosphate; Aldehydes; Animals; Cardiomyopathies; Cell Line; Creatine Kinase, MM Form; Disease Models, Animal; Frataxin; Friedreich Ataxia; Hydrazones; Iron; Iron Chelating Agents; Iron-Binding Proteins; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; NAD; Rats | 2020 |
SARM1 deficiency promotes rod and cone photoreceptor cell survival in a model of retinal degeneration.
Topics: Animals; Armadillo Domain Proteins; Cytoskeletal Proteins; Disease Models, Animal; Electroretinography; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Photoreceptor Cells; Retina; Retinal Cone Photoreceptor Cells; Retinal Degeneration; Retinal Rod Photoreceptor Cells; Retinitis Pigmentosa; Rhodopsin; Vision, Ocular | 2020 |
Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
Topics: Aged; Animals; Anti-Inflammatory Agents; Astrocytes; Behavior, Animal; Brain; Case-Control Studies; Disease Models, Animal; Energy Metabolism; Fatigue; Female; Gulf War; Humans; Male; Mice, Inbred C57BL; Middle Aged; Mitochondria; NAD; Niacinamide; Organelle Biogenesis; Oxidative Stress; Persian Gulf Syndrome; Pilot Projects; Pyridinium Compounds; Sirtuin 1; Veterans Health | 2020 |
An Alu-mediated duplication in NMNAT1, involved in NAD biosynthesis, causes a novel syndrome, SHILCA, affecting multiple tissues and organs.
Topics: Adolescent; Animals; Child; Child, Preschool; Disease Models, Animal; Exons; Genetic Predisposition to Disease; Hearing Loss, Sensorineural; Humans; Infant; Intellectual Disability; Leber Congenital Amaurosis; Male; Mice; Mutation; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Osteochondrodysplasias; Pedigree; Retinal Degeneration | 2020 |
NAD+ Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I Dysfunction.
Topics: Animals; Brain; Disease Models, Animal; Electron Transport Complex I; Female; Longevity; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; NAD; Saccharomyces cerevisiae | 2020 |
Muscle NAD
Topics: Activin Receptors; Activins; Acute-Phase Proteins; Animals; Cachexia; Cell Line, Tumor; Disease Models, Animal; Male; Mice; Mitochondria; Muscle, Skeletal; Muscular Atrophy; Myostatin; NAD; Oxidative Phosphorylation; Serpins | 2020 |
Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice.
Topics: Animals; Bariatric Surgery; Diet, High-Fat; Disease Models, Animal; Gastrectomy; Gene Expression; Male; Mice, Inbred C57BL; NAD; Non-alcoholic Fatty Liver Disease; Signal Transduction; Sirtuin 1; Up-Regulation | 2021 |
PARP1 Impedes SIRT1-Mediated Autophagy during Degeneration of the Retinal Pigment Epithelium under Oxidative Stress.
Topics: Animals; Autophagy; Disease Models, Animal; Humans; Hydrogen Peroxide; Iodates; Lysosomes; Macular Degeneration; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Oxidative Stress; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Retina; Retinal Pigment Epithelium; Sirtuin 1; Wortmannin | 2020 |
Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration.
Topics: Animals; Disease Models, Animal; Electroretinography; Fluorescent Antibody Technique; Injections, Intraperitoneal; Light; Male; Mice; Mice, Inbred BALB C; NAD; Niacinamide; Photoreceptor Cells, Vertebrate; Pyridinium Compounds; Retina; Retinal Degeneration; Tomography, Optical Coherence | 2020 |
Deletion of CD38 and supplementation of NAD
Topics: ADP-ribosyl Cyclase 1; Animals; Axons; Axotomy; Cell Count; Cells, Cultured; Dietary Supplements; Disease Models, Animal; Facial Nerve; Facial Nerve Diseases; Humans; Mice; Mice, Inbred ICR; Mice, Knockout; NAD; Nerve Degeneration | 2020 |
Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease.
Topics: Adenine; Animals; Citric Acid Cycle; Disease Models, Animal; Disease Progression; Energy Metabolism; Glycolysis; Kidney; Male; Metabolic Networks and Pathways; Metabolome; Mice; Mice, Inbred C57BL; NAD; Niacinamide; Renal Insufficiency; Renal Insufficiency, Chronic | 2021 |
Changes in NAD and Lipid Metabolism Drive Acidosis-Induced Acute Kidney Injury.
Topics: Acidosis; Acute Kidney Injury; Animals; Disease Models, Animal; Kidney Cortex; Kidney Tubules; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Oxygen Consumption | 2021 |
Structural basis for a complex I mutation that blocks pathological ROS production.
Topics: Amino Acid Substitution; Animals; Cryoelectron Microscopy; Disease Models, Animal; Disease Resistance; DNA, Mitochondrial; Electron Transport; Electron Transport Complex I; Humans; Isolated Heart Preparation; Leucine; Male; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Membranes; Myocardial Reperfusion Injury; NAD; NADH Dehydrogenase; Oxidation-Reduction; Point Mutation; Proline; Reactive Oxygen Species | 2021 |
Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration.
Topics: Animals; Apoptosis; Chromatography, Liquid; Disease Models, Animal; Humans; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mutation; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly Adenosine Diphosphate Ribose; Retina; Retinal Degeneration; Sirtuins; Tandem Mass Spectrometry | 2021 |
NAD
Topics: Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Case-Control Studies; Cell Line, Tumor; Dietary Supplements; Disease Models, Animal; Female; Fibroblasts; Humans; Male; Membrane Proteins; Mice; Mice, Knockout; Mitochondria; Mitophagy; NAD; Neurons; Niacinamide; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Senescence-Associated Secretory Phenotype; Signal Transduction; Transfection; Treatment Outcome | 2021 |
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
Topics: Albuminuria; Animals; Claudin-1; Cytokines; Diabetic Nephropathies; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Dose-Response Relationship, Drug; Epigenesis, Genetic; Glomerular Mesangium; Glycated Hemoglobin; Histones; Male; Mice; Mice, Knockout; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Podocytes; Sirtuin 1; Survival Rate; Time Factors | 2021 |
NMRK2 Gene Is Upregulated in Dilated Cardiomyopathy and Required for Cardiac Function and NAD Levels during Aging.
Topics: Aging; Animals; Cardiomegaly; Cardiomyopathy, Dilated; Cytosol; Disease Models, Animal; Electrocardiography; Gene Expression Regulation; Humans; Intracellular Signaling Peptides and Proteins; Laminin; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Up-Regulation; Ventricular Remodeling | 2021 |
Molecular imaging of NAD
Topics: Aging; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Mice; Mice, Transgenic; Molecular Imaging; NAD; Positron-Emission Tomography; Sirtuin 1 | 2021 |
NAD
Topics: Acetylation; Acyl-CoA Dehydrogenase; Animals; Disease Models, Animal; Down-Regulation; Fatty Acids; Heart Failure, Diastolic; Humans; Ketone Oxidoreductases; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Mitochondrial Myopathies; NAD; Niacinamide; Oxidation-Reduction; Oxygen Consumption; Pyridinium Compounds; Sirtuin 3 | 2021 |
Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cells, Cultured; Cytokines; Diabetic Cardiomyopathies; Diet, High-Fat; Disease Models, Animal; Fibrosis; Glutathione; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitophagy; Myocytes, Cardiac; NAD; NADP; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Rats, Wistar; Sirtuins; Thioredoxins | 2021 |
Modulation of NAD
Topics: Animals; Animals, Genetically Modified; Carboxy-Lyases; Cisplatin; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Hair Cells, Auditory; Hearing; Hearing Loss; Lateral Line System; Mice, Inbred C57BL; Mitochondria; NAD; Ototoxicity; Sirtuin 1; Zebrafish | 2021 |
NADPH is superior to NADH or edaravone in ameliorating metabolic disturbance and brain injury in ischemic stroke.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Edaravone; Infarction, Middle Cerebral Artery; Ischemic Stroke; Male; Mice; Mice, Inbred ICR; NAD; NADP; Neuroprotective Agents; Random Allocation; Reperfusion Injury; Stress, Physiological | 2022 |
Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Behavior, Animal; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Humans; Metabolome; Metabolomics; Mitochondria; Motor Activity; Mutation; NAD; Nerve Degeneration; Neurons; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Polymorphism, Single Nucleotide | 2021 |
Aberrant NAD
Topics: Animals; Brain; Cells, Cultured; Chromatography, Liquid; Disease Models, Animal; Disease Susceptibility; Female; Metabolomics; Mice; Microcephaly; NAD; Neurons; Pregnancy; Proteomics; Tandem Mass Spectrometry; Zika Virus; Zika Virus Infection | 2021 |
Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Eosinophils; Escape Reaction; Female; Hyperalgesia; Leukocyte Count; Locomotion; NAD; Neutrophils; Niacinamide; Nociception; Paclitaxel; Pain Measurement; Peripheral Nervous System Diseases; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Time Factors | 2017 |
Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.
Topics: Adenosine Triphosphatases; Animals; Dependovirus; Disease Models, Animal; Dogs; Female; Gait Disorders, Neurologic; Genetic Therapy; Glucuronidase; Humans; Longitudinal Studies; Microscopy, Electron; Muscle, Skeletal; Mutation; Myopathies, Structural, Congenital; NAD; Neurologic Examination; Protein Tyrosine Phosphatases, Non-Receptor; Respiration Disorders; Transduction, Genetic | 2017 |
Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.
Topics: Animals; Biomarkers; Brain Injuries; Cell Death; Cerebral Hemorrhage; Disease Models, Animal; Heme Oxygenase-1; Immunohistochemistry; Inflammation Mediators; Mice; Microglia; NAD; Neuroprotection; Neutrophil Infiltration; NF-E2-Related Factor 2; Nicotinamide Mononucleotide; Oxidative Stress; Protective Agents; Signal Transduction; Time Factors | 2017 |
Hyperbaric Oxygen Reduces Infarction Volume and Hemorrhagic Transformation Through ATP/NAD
Topics: Adenosine Triphosphate; Animals; Brain Ischemia; Cerebral Hemorrhage; Disease Models, Animal; Hyperbaric Oxygenation; Hyperglycemia; Infarction, Middle Cerebral Artery; Male; NAD; Nicotinamide Phosphoribosyltransferase; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1; Stroke | 2017 |
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Energy Metabolism; Gene Expression; Glucose; Glutamic Acid; Glutamine; Glycolysis; Heterografts; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lung Neoplasms; Mice; Mitochondria; Models, Biological; NAD; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Riluzole | 2017 |
Nicking Glaucoma with Nicotinamide?
Topics: Administration, Oral; Animals; Disease Models, Animal; Gene Expression; Genetic Therapy; Glaucoma; Humans; Intraocular Pressure; Mice; Mitochondria; NAD; Niacinamide; Retina; Vitamin B Complex | 2017 |
Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.
Topics: Acrylamides; Aminopyridines; Animals; Apoptosis; beta Catenin; Cell Proliferation; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Epithelial Cells; Female; Humans; Kidney; Male; Mice; Mice, Transgenic; NAD; Nicotinamide Phosphoribosyltransferase; Organ Culture Techniques; p21-Activated Kinases; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Receptors, Cell Surface; Signal Transduction; TRPP Cation Channels | 2017 |
Label-Free Fluorescence Spectroscopy for Detecting Key Biomolecules in Brain Tissue from a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Early Diagnosis; Flavin-Adenine Dinucleotide; Humans; Mice; Mice, Transgenic; NAD; Spectrometry, Fluorescence; Tryptophan | 2017 |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; Anal Canal; Animals; Congenital Abnormalities; Dietary Supplements; Disease Models, Animal; Esophagus; Female; Heart Defects, Congenital; Humans; Hydrolases; Kidney; Limb Deformities, Congenital; Male; Mice; Mice, Knockout; Mutation; NAD; Niacin; Sequence Analysis, DNA; Spine; Trachea | 2017 |
NMR Spectroscopy-based Metabolomics of Drosophila Model of Huntington's Disease Suggests Altered Cell Energetics.
Topics: Animals; Disease Models, Animal; Drosophila melanogaster; Energy Metabolism; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Spectroscopy; Metabolomics; NAD; Neurons; Peptides | 2017 |
Targeting the vulnerability to NAD
Topics: Acrylamides; Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokines; Disease Models, Animal; Female; Humans; Male; Mice; NAD; Nicotinamide Phosphoribosyltransferase; p21-Activated Kinases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |
Use of immunoproteomics to identify immunogenic proteins in a rat model of acute respiratory distress syndrome.
Topics: Animals; Autoantibodies; Cecum; Choline; Computational Biology; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Gluconeogenesis; Glycolysis; Heme; Humans; Lung; Male; NAD; Punctures; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Signal Transduction | 2017 |
Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Disease Models, Animal; Homeostasis; Humans; Male; Memory; Mice; Mice, Transgenic; Mitochondria; Mitophagy; NAD; Niacinamide; Oxidative Phosphorylation; Protein Aggregation, Pathological; Protein Biosynthesis; Proteostasis; Pyridinium Compounds; Unfolded Protein Response | 2017 |
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
Topics: Acrylamides; AMP-Activated Protein Kinases; Animals; Cardiomyopathy, Dilated; Citric Acid; Cytokines; Dietary Supplements; Disease Models, Animal; Gene Expression Profiling; Heart Failure; Metabolome; Mice; Mice, Transgenic; Myocytes, Cardiac; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Phosphotransferases (Alcohol Group Acceptor); Piperidines; PPAR alpha; Pyridinium Compounds; Rats; Serum Response Factor | 2018 |
Metabolic and vascular pattern in medial pterygoid muscle is altered by chronic stress in an animal model of hypodontia.
Topics: Animals; Capillaries; Chronic Disease; Corticosterone; Disease Models, Animal; Male; Molar; NAD; Pterygoid Muscles; Random Allocation; Rats, Wistar; Reactive Oxygen Species; Stress, Psychological; Succinate Dehydrogenase; Temporomandibular Joint Disorders; Tooth Extraction; Uncertainty | 2018 |
Renal Tubular Cell Mitochondrial Dysfunction Occurs Despite Preserved Renal Oxygen Delivery in Experimental Septic Acute Kidney Injury.
Topics: Acute Kidney Injury; Animals; Cell Survival; Disease Models, Animal; Kidney Function Tests; Kidney Tubules; Male; Membrane Potential, Mitochondrial; Mitochondria; NAD; Oxygen; Oxygen Consumption; Prospective Studies; Rats; Rats, Wistar; Reactive Oxygen Species; Renal Circulation; Sepsis | 2018 |
Segmented cell analyses to measure redox states of autofluorescent NAD(P)H, FAD & Trp in cancer cells by FLIM.
Topics: Animals; Cytosol; Disease Models, Animal; Doxorubicin; Flavin-Adenine Dinucleotide; Glucose; Heterografts; Humans; Microscopy, Fluorescence; Mitochondria; Molecular Imaging; NAD; NADP; Neoplasms; Oxidation-Reduction; Oxidative Phosphorylation | 2018 |
N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Proliferation; Disease Models, Animal; Disease Progression; Energy Metabolism; Kidney; Male; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Mitochondria; NAD; Oxidative Stress; Phosphorylation; PPAR gamma; Renal Insufficiency, Chronic; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2018 |
A specific amino acid formula prevents alcoholic liver disease in rodents.
Topics: Alcohol Drinking; Amino Acids, Branched-Chain; Animals; Dietary Supplements; Disease Models, Animal; Energy Metabolism; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Liver; Mitochondria; Mitochondrial Diseases; NAD; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species | 2018 |
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Fatty Liver; Healthy Aging; Inflammation; Liver; Longevity; Mice, Inbred C57BL; NAD; Niacinamide; Oxidative Stress; Sirtuin 1 | 2018 |
Phasor analysis of NADH FLIM identifies pharmacological disruptions to mitochondrial metabolic processes in the rodent cerebral cortex.
Topics: Animals; Bicuculline; Biomarkers; Cerebral Cortex; Disease Models, Animal; Humans; Intravital Microscopy; Microscopy, Fluorescence, Multiphoton; Mitochondria; Models, Biological; NAD; Nonlinear Dynamics; Rats, Sprague-Dawley; Rodentia; Seizures | 2018 |
Estrogen receptor β activation within dorsal raphe nucleus reverses anxiety-like behavior induced by food restriction in female rats.
Topics: Adipose Tissue; Animals; Anxiety; Disease Models, Animal; Estradiol; Estrogen Receptor beta; Estrous Cycle; Female; Food Deprivation; Locomotion; Maze Learning; Microinjections; NAD; Raphe Nuclei; Rats; Rats, Inbred F344; Uterus | 2019 |
2,4 Dinitrophenol Attenuates Mitochondrial Dysfunction and Improves Neurobehavioral Outcomes Postanoxia in Neonatal Rats.
Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Animals, Newborn; bcl-2-Associated X Protein; Caspases; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypoxia; Membrane Potential, Mitochondrial; Mental Disorders; Mitochondrial Diseases; NAD; Oxidative Stress; Oxidoreductases; Pregnancy; Rats; Succinate Dehydrogenase | 2018 |
Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analgesics, Non-Narcotic; Animals; Autophagy; Beclin-1; Carbamazepine; Disease Models, Animal; Drug Repositioning; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Muscle, Skeletal; NAD; Protein Aggregation, Pathological; Signal Transduction; Superoxide Dismutase | 2018 |
NNMT activation can contribute to the development of fatty liver disease by modulating the NAD
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Fatty Liver; Lipoproteins, VLDL; Liver; Liver Cirrhosis; Methionine; Mice, Inbred C57BL; Mice, Transgenic; NAD; Niacinamide; Nicotinamide N-Methyltransferase | 2018 |
The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease.
Topics: Animals; Autophagy; Disease Models, Animal; Dopaminergic Neurons; Drosophila melanogaster; Endoplasmic Reticulum Stress; Glucosylceramidase; Humans; Induced Pluripotent Stem Cells; Mitochondria; Mitochondrial Dynamics; Motor Activity; NAD; Neurons; Niacinamide; Parkinson Disease; Pyridinium Compounds; Unfolded Protein Response | 2018 |
Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A/C gene mutation.
Topics: Animals; Cardiomyopathies; Disease Models, Animal; Heart; Heart Failure; Heart Ventricles; Humans; Lamin Type A; Mice; Mutation; NAD; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Poly ADP Ribosylation; Ventricular Dysfunction, Left | 2018 |
De novo NAD
Topics: Animals; Caenorhabditis elegans; Carboxy-Lyases; Cell Line; Choline; Conserved Sequence; Disease Models, Animal; Evolution, Molecular; Female; Gene Knockdown Techniques; Health; Hepatocytes; Homeostasis; Humans; Kidney; Liver; Longevity; Male; Methionine; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Non-alcoholic Fatty Liver Disease; Rats; Sirtuins | 2018 |
Ferulic acid potentiates the antibacterial activity of quinolone-based antibiotics against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Coumaric Acids; Disease Models, Animal; Drug Combinations; Drug Synergism; Electron Transport; Energy Metabolism; Glutathione; Male; Mice; Microbial Sensitivity Tests; NAD; Quinolones; Reactive Oxygen Species | 2019 |
Rapid Assessment of Mitochondrial Complex I Activity and Metabolic Phenotyping of Breast Cancer Cells by NAD(p)H Cytometry.
Topics: Animals; Breast Neoplasms; Cell Plasticity; Disease Models, Animal; Electron Transport Complex I; Female; Flow Cytometry; Humans; MCF-7 Cells; Mice; Mitochondria; NAD; Single-Cell Analysis | 2019 |
Age- and AD-related redox state of NADH in subcellular compartments by fluorescence lifetime imaging microscopy.
Topics: Aging; Alzheimer Disease; Animals; Disease Models, Animal; Genotype; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Optical Imaging; Oxidation-Reduction; Oxidative Phosphorylation; Sex Characteristics; tau Proteins | 2019 |
An NAD
Topics: Animals; Antibiotics, Antitubercular; Antitoxins; Bacterial Load; Bacterial Proteins; Bacterial Toxins; Cells, Cultured; Disease Models, Animal; Female; Host-Pathogen Interactions; Humans; Kinetics; Macrophages; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Microbial Viability; Models, Molecular; Mycobacterium smegmatis; Mycobacterium tuberculosis; NAD; Phosphorylases; Protein Conformation; Toxin-Antitoxin Systems; Tuberculosis | 2019 |
NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
Topics: Adenoviridae; Animals; Cells, Cultured; Cytokines; Disease Models, Animal; Down-Regulation; Ethanol; Fatty Liver, Alcoholic; Gene Knockdown Techniques; Genetic Therapy; Hepatocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Nicotinamide Phosphoribosyltransferase; Recombinant Fusion Proteins; Sirtuin 1; Sirtuins; Triglycerides; Up-Regulation | 2019 |
Targeting NAD
Topics: Animals; Brain; Disease Models, Animal; Electron Transport Complex I; Female; Leigh Disease; Longevity; Male; Mice; Mice, Knockout; Mitochondria; Molecular Targeted Therapy; NAD; Nicotinamide Mononucleotide | 2019 |
Microwave ablation zones are larger than they macroscopically appear - Reevaluation based on NADH vitality staining ex vivo.
Topics: Ablation Techniques; Animals; Catheter Ablation; Disease Models, Animal; NAD; Research Design; Staining and Labeling; Swine | 2019 |
Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
Topics: Animals; Body Weight; Collagen; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Energy Metabolism; Hepatic Stellate Cells; Humans; Liver; Mice; Mice, Inbred C57BL; Muscle, Skeletal; NAD; Niacinamide; Non-alcoholic Fatty Liver Disease; Pyridinium Compounds | 2019 |
Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease.
Topics: Animals; Cell Survival; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Male; Mice; Microinjections; Mitochondria; Motor Activity; NAD; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary | 2019 |
The sirtuin family in cancer.
Topics: Animals; Carcinogenesis; Disease Models, Animal; Enzyme Activation; Histone Deacetylase Inhibitors; Humans; Mice; NAD; Neoplasms; Sirtuins | 2019 |
Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Autophagy; Cardiotoxicity; Cells, Cultured; Cytoprotection; Disease Models, Animal; Doxorubicin; Heart Diseases; Hydrogen-Ion Concentration; Lysosomes; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; NAD; Niacinamide; Oxidative Stress; Pyridinium Compounds; Sirtuin 1 | 2019 |
Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites.
Topics: Aging; Alzheimer Disease; Animals; Brain; Caenorhabditis elegans Proteins; Carrier Proteins; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Male; Metabolome; Mice; Mice, Transgenic; NAD; NADP; Oxidation-Reduction | 2019 |
Effects of propofol on myocardial ischemia reperfusion injury through inhibiting the JAK/STAT pathway.
Topics: Animals; Disease Models, Animal; Gene Expression Regulation; Janus Kinase 1; L-Lactate Dehydrogenase; Myocardial Reperfusion Injury; NAD; Phosphorylation; Propofol; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Treatment Outcome | 2019 |
Reversibility of Age-related Oxidized Free NADH Redox States in Alzheimer's Disease Neurons by Imposed External Cys/CySS Redox Shifts.
Topics: Aging; Alzheimer Disease; Animals; Cell Nucleus; Cells, Cultured; Cellular Senescence; Cysteine; Cystine; Cytoplasm; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Humans; Intravital Microscopy; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Oxidation-Reduction; Oxidative Stress; Primary Cell Culture | 2019 |
NAD+ and nicotinamide: sex differences in cerebral ischemia.
Topics: Analysis of Variance; Animals; Brain Ischemia; Caspase 3; Disease Models, Animal; Female; Male; Mice; Mice, Knockout; NAD; Niacinamide; Ovariectomy; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Sex Characteristics; Spectrin; Subcellular Fractions | 2013 |
Organ specific optical imaging of mitochondrial redox state in a rodent model of hereditary hemorrhagic telangiectasia-1.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Endoglin; Eye; Flavin-Adenine Dinucleotide; Freezing; Imaging, Three-Dimensional; Intracellular Signaling Peptides and Proteins; Kidney; Lung; Mice, Transgenic; Mitochondria; NAD; Optical Imaging; Oxidative Stress; Reactive Oxygen Species; Telangiectasia, Hereditary Hemorrhagic | 2014 |
Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Glutamate-Cysteine Ligase; Glutathione; Glycyrrhetinic Acid; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; NAD; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Niacinamide; Oxidation-Reduction; Reactive Oxygen Species | 2014 |
Integrated proteomic and metabolomic analysis reveals the NADH-mediated TCA cycle and energy metabolism disorders based on a new model of chronic progressive heart failure.
Topics: Animals; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Heart Failure; Humans; Malate Dehydrogenase; Metabolomics; Myocardial Ischemia; NAD; NADH Dehydrogenase; Proteomics; Swine; Swine, Miniature | 2013 |
Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Flavin-Adenine Dinucleotide; Glycolysis; Humans; Mice; Mice, Nude; NAD; Optical Imaging; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays | 2013 |
Resveratrol delays Wallerian degeneration in a NAD(+) and DBC1 dependent manner.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antioxidants; Cells, Cultured; Disease Models, Animal; Ganglia, Spinal; Humans; In Vitro Techniques; Mice; NAD; Neurofilament Proteins; Neurons; Resveratrol; RNA-Binding Proteins; Sciatic Nerve; Sirtuin 1; Stilbenes; Time Factors; Transfection; Wallerian Degeneration | 2014 |
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody.
Topics: Acrylamides; Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Biosynthetic Pathways; Caspase 3; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Humans; Lymphoma; Membrane Potential, Mitochondrial; Mice; Mice, SCID; NAD; Piperidines; Reactive Oxygen Species; Rituximab; Xenograft Model Antitumor Assays | 2014 |
Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; DNA, Mitochondrial; Energy Metabolism; Glucose; Glucose Tolerance Test; Insulin Resistance; Liver; Male; Mitochondrial Turnover; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Inbred OLETF; Signal Transduction; Sirtuin 1; Sirtuins; Transcription Factors | 2014 |
Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo.
Topics: Animals; Disease Models, Animal; Electron Transport Complex I; Female; Gene Products, tat; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; NAD; Rats; Rats, Sprague-Dawley | 2014 |
Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis.
Topics: Animals; Bile Acids and Salts; Circadian Clocks; Circadian Rhythm; Disease Models, Animal; Ethanol; Fatty Liver, Alcoholic; Gene Expression Profiling; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Mice; NAD; Period Circadian Proteins | 2014 |
Elimination of NADPH oxidase activity promotes reductive stress and sensitizes the heart to ischemic injury.
Topics: Animals; Disease Models, Animal; Energy Metabolism; Glutathione; Mice; Mice, Knockout; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NAD; NADPH Oxidase 4; NADPH Oxidases; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Time Factors | 2014 |
SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis.
Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; DNA, Mitochondrial; Dose-Response Relationship, Drug; Drug Repositioning; Energy Metabolism; Enzyme Activation; Enzyme Activators; Fatty Liver; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Male; Methylene Blue; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial Turnover; NAD; Rats; RNA Interference; Sirtuin 1; Time Factors; Transfection | 2014 |
Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury.
Topics: Acrylamides; Animals; Anti-Inflammatory Agents; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Inflammation Mediators; Lung; Mice; Mice, Inbred C57BL; NAD; Neutrophils; Nicotinamide Phosphoribosyltransferase; Piperidines; Pneumonia; Respiratory Distress Syndrome; Ventilator-Induced Lung Injury | 2014 |
NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Electron Transport Complex IV; Energy Metabolism; Enzyme Activation; Gene Expression; Mice; Mice, Knockout; Mitochondria; Mitochondrial Diseases; Molecular Chaperones; NAD; Niacinamide; Oxidative Phosphorylation; Phenanthrenes; Phenotype; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyridinium Compounds; Sirtuin 1 | 2014 |
Beyond Warburg effect--dual metabolic nature of cancer cells.
Topics: Acidosis, Lactic; Animals; Biological Transport; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Glucose; Glycolysis; Heterografts; Humans; Hydrogen-Ion Concentration; Lactic Acid; Mice; NAD; Neoplasms; Oxygen Consumption; Phenotype | 2014 |
NAD+ protects against EAE by regulating CD4+ T-cell differentiation.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Homeostasis; Mice; Multiple Sclerosis; Myelin Sheath; NAD; Regeneration; Tryptophan Hydroxylase | 2014 |
Sorbitol dehydrogenase inhibitor protects the liver from ischemia/reperfusion-induced injury via elevated glycolytic flux and enhanced sirtuin 1 activity.
Topics: Animals; Caspase 3; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Glycolysis; Hepatocytes; L-Iditol 2-Dehydrogenase; Liver; Male; Mice; NAD; Protective Agents; Reperfusion Injury; Sirtuin 1 | 2015 |
Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cardiotonic Agents; Cytoprotection; Disease Models, Animal; Enzyme Activation; Heart Rate; Male; MAP Kinase Signaling System; Methyl Ethers; Mitochondria, Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NAD; Perfusion; Phosphorylation; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Sevoflurane; Time Factors; Ventricular Function, Left | 2014 |
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.
Topics: Adenosine Monophosphate; Animals; Aspartic Acid; Citric Acid Cycle; Disease Models, Animal; Electron Transport; Electron Transport Complex I; Fumarates; Ischemia; Malates; Male; Metabolomics; Mice; Mitochondria; Myocardial Infarction; Myocardium; Myocytes, Cardiac; NAD; Reactive Oxygen Species; Reperfusion Injury; Stroke; Succinate Dehydrogenase; Succinic Acid | 2014 |
Theobromine increases NAD⁺/Sirt-1 activity and protects the kidney under diabetic conditions.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Kidney; Male; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Sirtuin 1; Theobromine | 2015 |
Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease.
Topics: Animals; Antioxidants; Caffeine; Cell Respiration; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Flavin-Adenine Dinucleotide; Huntington Disease; Mitochondria; NAD; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Quinolinic Acid; Rats | 2014 |
High level of oxygen treatment causes cardiotoxicity with arrhythmias and redox modulation.
Topics: Action Potentials; Animals; Biomarkers; Bradycardia; Cell Line; Disease Models, Animal; Electrocardiography; Heart Conduction System; Heart Rate; Histone Deacetylase Inhibitors; Hyperoxia; Kv1.5 Potassium Channel; L-Lactate Dehydrogenase; Mice; Myocytes, Cardiac; NAD; NADP; Oxidation-Reduction; Oxidative Stress; Rats; Signal Transduction; Sirtuin 1; Time Factors; Troponin I | 2015 |
Reversing neurodegenerative hearing loss.
Topics: Animals; Disease Models, Animal; Hearing Loss; Humans; Mice; Mice, Knockout; NAD; Neurodegenerative Diseases; Niacinamide; Pyridinium Compounds; Sirtuin 3 | 2015 |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.
Topics: Animals; Creatinine; Cyclosporine; Disease Models, Animal; Glutathione; Glutathione Disulfide; Kidney; Kidney Diseases; Male; NAD; NADP; PPAR gamma; Prostaglandin D2; Protective Agents; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Urea; Uric Acid | 2014 |
NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
Topics: Acrylamides; Acute Disease; Animals; Astrocytes; Brain; Brain Injuries; Calcium-Binding Proteins; Cell Count; Chronic Disease; Cold Temperature; Cytokines; Disease Models, Animal; Macrophages; Male; Mice, Inbred BALB C; Microfilament Proteins; Microglia; NAD; Neurons; Neuroprotective Agents; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Piperidines | 2015 |
The brain metabolic activity after resuscitation with liposome-encapsulated hemoglobin in a rat model of hypovolemic shock.
Topics: Adenosine Triphosphate; Animals; Blood Substitutes; Brain; Citrate (si)-Synthase; Disease Models, Animal; Glucose-6-Phosphate; Hemoglobins; Hexokinase; Liposomes; Male; NAD; Nerve Growth Factor; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Resuscitation; Shock | 2015 |
Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy.
Topics: Animals; Calcium; Cells, Cultured; Cyclosporine; Cytosol; Disease Models, Animal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Muscular Dystrophy, Duchenne; Myocytes, Cardiac; NAD; Oxidative Stress; Sodium | 2015 |
Oral dependent-dose toxoplasmic infection model induced by oocysts in rats: Myenteric plexus and jejunal wall changes.
Topics: Animals; Antibodies, Protozoan; Disease Models, Animal; Histocytochemistry; Immunoglobulin G; Jejunum; Male; Myenteric Plexus; NAD; NADP; Neurons; Random Allocation; Rats; Rats, Wistar; Toxoplasma; Toxoplasmosis, Animal | 2015 |
Effects of p67phox on the mitochondrial oxidative state in the kidney of Dahl salt-sensitive rats: optical fluorescence 3-D cryoimaging.
Topics: Animals; Disease Models, Animal; Flavin-Adenine Dinucleotide; Frozen Sections; Genotype; Hypertension; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kidney; Male; Microscopy, Fluorescence; Mitochondria; NAD; Oxidation-Reduction; Oxidative Stress; Phenotype; Phosphoproteins; Rats, Inbred Dahl; Rats, Transgenic; Sodium Chloride, Dietary; Time Factors | 2015 |
NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
Topics: Amino Acids; Animals; Biomarkers; Citric Acid Cycle; Disease Models, Animal; Female; Glucocorticoids; Humans; Hydroxybutyrates; Kidney; Magnetic Resonance Spectroscopy; Metabolic Diseases; Metabolome; Metabolomics; Mice; Mitochondria; NAD; Oxidative Stress; Pentose Phosphate Pathway; Polycystic Ovary Syndrome | 2015 |
Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.
Topics: AMP-Activated Protein Kinases; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dependovirus; Disease Models, Animal; Energy Metabolism; Gene Expression; Genetic Therapy; Genetic Vectors; Glucose-6-Phosphatase; Glycogen Storage Disease Type I; Insulin Resistance; Liver; Mice; Mice, Knockout; NAD; Nuclear Proteins; Obesity; Signal Transduction; Sirtuin 1; Transcription Factors | 2015 |
Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Cytoprotection; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; Heat-Shock Proteins; Liver; Liver Transplantation; Losartan; Male; Mitogen-Activated Protein Kinases; NAD; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Signal Transduction; Sirtuin 1 | 2015 |
Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model.
Topics: Adenosine Triphosphate; Animals; Benzylidene Compounds; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Energy Metabolism; Male; Mitochondria; NAD; Nerve Growth Factor; Neuroprotective Agents; Phosphocreatine; Piperidones; Pyruvic Acid; Rats, Sprague-Dawley; Shock, Hemorrhagic | 2015 |
Characterization of NAD salvage pathways and their role in virulence in Streptococcus pneumoniae.
Topics: Animals; Disease Models, Animal; Gene Deletion; Membrane Transport Proteins; Mice; NAD; Pneumococcal Infections; Streptococcus pneumoniae; Substrate Specificity; Virulence; Virulence Factors | 2015 |
Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.
Topics: Acetylation; Animals; Cisplatin; Cochlea; Cytoprotection; Disease Models, Animal; Hearing; Hearing Loss; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Poly (ADP-Ribose) Polymerase-1; Protective Agents; Signal Transduction; Sirtuin 1; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2016 |
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
Topics: Analysis of Variance; Animals; Area Under Curve; Biopsy, Needle; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Immunohistochemistry; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Niacinamide; Pyridinium Compounds; Random Allocation; Sensitivity and Specificity; Treatment Outcome; Unfolded Protein Response | 2016 |
Estrogen receptor beta signaling alters cellular inflammasomes activity after global cerebral ischemia in reproductively senescence female rats.
Topics: Aging; Animals; Apoptosis Regulatory Proteins; Brain Ischemia; CARD Signaling Adaptor Proteins; Caspase 1; Cytokines; Disease Models, Animal; Estrogen Receptor beta; Female; Hippocampus; Immunity, Innate; Inflammasomes; NAD; Neurons; Oligodeoxyribonucleotides, Antisense; Ovariectomy; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |
Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by global cerebral ischemia/reperfusion injury in rats.
Topics: Active Transport, Cell Nucleus; Animals; Brain Ischemia; CA1 Region, Hippocampal; Cathepsin B; Cell Hypoxia; Cells, Cultured; Dipeptides; Disease Models, Animal; Glucose; HSP70 Heat-Shock Proteins; Male; NAD; Necrosis; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinases; Reperfusion Injury | 2016 |
True Niacin Deficiency in Quinolinic Acid Phosphoribosyltransferase (QPRT) Knockout Mice.
Topics: Animals; Disease Models, Animal; Mice, Inbred C57BL; Mice, Knockout; Mutation; NAD; Niacin; Nutritional Status; Pentosyltransferases; Quinolinic Acid; Vitamin B Deficiency | 2015 |
Experimental evidence that overexpression of NR2B glutamate receptor subunit is associated with brain vacuolation in adult glutaryl-CoA dehydrogenase deficient mice: A potential role for glutamatergic-induced excitotoxicity in GA I neuropathology.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; Brain Injuries; Catalase; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Fluoresceins; Gene Expression Regulation; Glucosephosphate Dehydrogenase; Glutaryl-CoA Dehydrogenase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Malondialdehyde; Mice; Mice, Transgenic; NAD; Receptors, N-Methyl-D-Aspartate; Sulfhydryl Compounds; Superoxide Dismutase | 2015 |
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells.
Topics: Adipose Tissue, White; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Atenolol; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Electron Transport Complex I; Female; Humans; Metformin; NAD; Neoplasm Metastasis; Stem Cells; Triple Negative Breast Neoplasms; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2016 |
Involvement of NADH Oxidase in Competition and Endocarditis Virulence in Streptococcus sanguinis.
Topics: Aerobiosis; Animals; Antibiosis; Disease Models, Animal; Endocarditis, Bacterial; Gene Knockout Techniques; Humans; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Rabbits; Streptococcal Infections; Streptococcus mutans; Streptococcus sanguis; Virulence; Virulence Factors | 2016 |
Blocking NAD(+)/CD38/cADPR/Ca(2+) pathway in sepsis prevents organ damage.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Calcium; Calcium Signaling; Cyclic ADP-Ribose; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Malondialdehyde; Membrane Glycoproteins; Multiple Organ Failure; NAD; Random Allocation; Rats, Sprague-Dawley; Sepsis; Superoxide Dismutase | 2016 |
Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease.
Topics: Animals; Blotting, Western; Brain; Dietary Supplements; Disease Models, Animal; Dopaminergic Neurons; Drosophila; Drosophila Proteins; Genotype; Longevity; Male; Membrane Potential, Mitochondrial; Mitochondria; Mutagenesis; NAD; Niacinamide; Parkinson Disease; Poly(ADP-ribose) Polymerases; Ubiquitin-Protein Ligases | 2016 |
Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Gene Amplification; Glioblastoma; Glucose; Glycolysis; Humans; Mice; NAD; Nicotinamide Phosphoribosyltransferase; Proto-Oncogene Proteins c-myc; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2016 |
NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice.
Topics: Animals; Cellular Reprogramming; Cellular Senescence; Disease Models, Animal; Longevity; Melanocytes; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mitochondria; Muscular Dystrophies; Myoblasts, Skeletal; NAD; Neural Stem Cells; Niacinamide; Oxidative Stress; Prohibitins; Pyridinium Compounds; Repressor Proteins; Unfolded Protein Response | 2016 |
Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory; Mitochondria; NAD; Neurons; Neuroprotective Agents; Nicotinamide Mononucleotide; Peptide Fragments; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Tissue Culture Techniques | 2016 |
Dynamic Cerebrovascular and Intracranial Pressure Reactivity Assessment of Impaired Cerebrovascular Autoregulation in Intracranial Hypertension.
Topics: Animals; Arterial Pressure; Blood-Brain Barrier; Capillary Permeability; Cerebrovascular Circulation; Cisterna Magna; Disease Models, Animal; Dopamine; Hemodynamics; Homeostasis; Intracranial Hypertension; Intracranial Pressure; Male; Microscopy, Confocal; NAD; Rats; Rats, Sprague-Dawley; Sympathomimetics | 2016 |
Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke.
Topics: Animals; Brain Infarction; Carbazoles; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucose; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; NAD; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Tubulin | 2016 |
α7 Nicotinic Acetylcholine Receptor Relieves Angiotensin II-Induced Senescence in Vascular Smooth Muscle Cells by Raising Nicotinamide Adenine Dinucleotide-Dependent SIRT1 Activity.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Genotype; Histone Deacetylase Inhibitors; Humans; Hypertension; Mice, Knockout; Muscle, Smooth, Vascular; NAD; Nicotinic Agonists; Oxidative Stress; Phenotype; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Sirtuin 1; Time Factors; Transfection; Up-Regulation | 2016 |
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.
Topics: Acrylamides; Aminopyridines; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Humans; Kidney Neoplasms; Male; Mice; Molecular Targeted Therapy; NAD; Nicotinamide Phosphoribosyltransferase; p21-Activated Kinases; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Mitochondrial complex I dysfunction and altered NAD(P)H kinetics in rat myocardium in cardiac right ventricular hypertrophy and failure.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Heart; Hypertrophy, Right Ventricular; Male; Mitochondria; Myocardium; NAD; NADP; Oxygen Consumption; Rats, Wistar | 2016 |
Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
Topics: Animals; Brain Injuries; Brain Ischemia; Cell Death; Disease Models, Animal; Hippocampus; Male; Mice, Inbred C57BL; NAD; Niacinamide; Nicotinamide Mononucleotide | 2016 |
Improvement of Impaired Cerebral Microcirculation Using Rheological Modulation by Drag-Reducing Polymers.
Topics: Animals; Blood Flow Velocity; Blood-Brain Barrier; Brain Injuries, Traumatic; Capillary Permeability; Cell Hypoxia; Cerebrovascular Circulation; Disease Models, Animal; Hemorheology; Infarction, Middle Cerebral Artery; Male; Microcirculation; Microscopy, Fluorescence, Multiphoton; Middle Cerebral Artery; Molecular Weight; NAD; Neurons; Neuroprotective Agents; Parietal Lobe; Polyethylene Glycols; Rats, Sprague-Dawley; Stress, Mechanical; Time Factors | 2016 |
Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Line, Tumor; CHO Cells; Citrate (si)-Synthase; Cricetulus; Disease Models, Animal; Electron Transport Complex IV; Entorhinal Cortex; Enzyme Inhibitors; Hippocampus; Lactic Acid; Membrane Potential, Mitochondrial; Mice, Transgenic; Mitochondria; NAD; Neuroprotective Agents; Peptide Fragments; Poly (ADP-Ribose) Polymerase-1 | 2016 |
Dynamin-Related Protein 1 Promotes Mitochondrial Fission and Contributes to The Hippocampal Neuronal Cell Death Following Experimental Status Epilepticus.
Topics: Animals; Apoptosis; Caspase 3; Disease Models, Animal; Dynamins; Excitatory Amino Acid Agonists; Functional Laterality; Gene Expression Regulation; Hippocampus; Kainic Acid; Male; Mitochondrial Dynamics; NAD; Neurons; Phosphopyruvate Hydratase; Quinazolinones; Rats; Rats, Sprague-Dawley; Serine; Status Epilepticus | 2016 |
Avian axons undergo Wallerian degeneration after injury and stress.
Topics: Analysis of Variance; Animals; Axons; Axotomy; Calcium; Cells, Cultured; Disease Models, Animal; Finches; Microscopy, Confocal; Microscopy, Fluorescence; NAD; Nerve Degeneration; Paclitaxel; Pressure; Retinal Ganglion Cells; Stress, Physiological; Vincristine; Wallerian Degeneration | 2016 |
Striatal mitochondria response to 3-nitropropionic acid and fish oil treatment.
Topics: Animals; Antioxidants; Corpus Striatum; Cytochrome-c Peroxidase; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Complex II; Electron Transport Complex IV; Fish Oils; Huntington Disease; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Mitochondria; NAD; Neuroprotective Agents; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar | 2018 |
Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo.
Topics: Animals; Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Male; Mice; NAD; Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Small Molecule Libraries; Xenograft Model Antitumor Assays | 2016 |
NAD
Topics: Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Behavior, Animal; Caenorhabditis elegans; Cells, Cultured; Disease Models, Animal; DNA Repair; Gene Knockdown Techniques; Health; Homeostasis; Longevity; Metabolomics; Mice; Mitophagy; NAD; Neurons; Phenotype; Phthalazines; Piperazines; Proteomics; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1 | 2016 |
Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration.
Topics: Animals; Disease Models, Animal; Fluorescent Antibody Technique; Hepatectomy; Immunoblotting; Immunohistochemistry; Liver; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Niacinamide; Pyridinium Compounds; Random Allocation; Sensitivity and Specificity | 2017 |
Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity.
Topics: Acetylation; Adenylate Kinase; AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Regulation; Lipid Metabolism; Male; NAD; Non-alcoholic Fatty Liver Disease; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Sirtuin 1; Up-Regulation | 2016 |
Key role of an ADP - ribose - dependent transcriptional regulator of NAD metabolism for fitness and virulence of Pseudomonas aeruginosa.
Topics: Adenosine Diphosphate Ribose; Animals; Bacterial Proteins; Cricetulus; Disease Models, Animal; Female; Gene Expression Regulation, Bacterial; Mice, Inbred C3H; NAD; Operon; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Transcription Factors; Virulence | 2017 |
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Fatty Liver, Alcoholic; Humans; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Nitrosative Stress; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenanthrenes; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinolines; Sirtuin 1 | 2017 |
NADH fluorescence imaging and the histological impact of cortical spreading depolarization during the acute phase of subarachnoid hemorrhage in rats.
Topics: Acute Disease; Animals; Brain; Cerebrovascular Circulation; Cortical Spreading Depression; Disease Models, Animal; Fluorescent Dyes; Intracranial Pressure; Male; NAD; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 2018 |
Personal model-assisted identification of NAD
Topics: Animals; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Genome; Glutathione; Glycine; Humans; Lipoproteins; Liver; Male; Metabolomics; Mice; Middle Aged; NAD; Non-alcoholic Fatty Liver Disease; Patient-Specific Modeling; Serine | 2017 |
Quantification of in vivo autofluorescence dynamics during renal ischemia and reperfusion under 355 nm excitation.
Topics: Animals; Biomarkers; Diagnosis, Computer-Assisted; Disease Models, Animal; Kidney; Male; NAD; Rats; Rats, Inbred WF; Reperfusion Injury; Sensitivity and Specificity; Spectrometry, Fluorescence | 2008 |
Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching.
Topics: Animals; Biological Transport; Calcium; Disease Models, Animal; Electrophysiology; Energy Metabolism; Guinea Pigs; Heart Failure; Mitochondria, Heart; Myocytes, Cardiac; NAD; Sodium; Sodium-Calcium Exchanger | 2008 |
Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Levodopa; Mitochondria; NAD; Neurons; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Rats; Rotenone; Spectrophotometry; Ubiquinone; Ultrasonography; Vitamins | 2008 |
Dynamic changes in cortical NADH fluorescence in rat focal ischemia: evaluation of the effects of hypothermia on propagation of peri-infarct depolarization by temporal and spatial analysis.
Topics: Animals; Brain Infarction; Brain Ischemia; Cerebral Cortex; Cortical Spreading Depression; Disease Models, Animal; Electroencephalography; Fluorescence; Hypothermia, Induced; Linear Models; Male; NAD; Rats; Rats, Inbred SHR; Time Factors | 2009 |
Real-time monitoring of mitochondrial NADH and microcirculatory blood flow in the spinal cord.
Topics: Animals; Disease Models, Animal; Ischemia; Laminectomy; Laser-Doppler Flowmetry; Lumbar Vertebrae; Male; Microcirculation; Mitochondria; Monitoring, Physiologic; NAD; Rats; Rats, Wistar; Regional Blood Flow; Spectrometry, Fluorescence; Spinal Cord | 2008 |
Renal viability evaluated by the multiprobe assembly: a unique tool for the assessment of renal ischemic injury.
Topics: Acute Kidney Injury; Animals; Cell Hypoxia; Disease Models, Animal; Electrodes, Implanted; Equipment Design; Fluorometry; Graft Survival; Homeostasis; Kidney; Kidney Function Tests; Laser-Doppler Flowmetry; Male; Microelectrodes; Mitochondria; NAD; Oxidation-Reduction; Potassium; Protons; Rats; Rats, Wistar; Renal Circulation; Reperfusion Injury | 2009 |
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
Topics: Adenylate Kinase; Animals; Disease Models, Animal; Energy Metabolism; Metabolic Syndrome; Mice; Mice, Knockout; NAD; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Naphthoquinones; Obesity; Oxidation-Reduction; Phenotype; Signal Transduction | 2009 |
Contribution of nitric oxide, superoxide anion, and peroxynitrite to activation of mitochondrial apoptotic signaling in hippocampal CA3 subfield following experimental temporal lobe status epilepticus.
Topics: Analysis of Variance; Animals; Apoptosis; Caspase 3; Disease Models, Animal; DNA Fragmentation; Electroencephalography; Electron Transport Complex III; Enzyme Activation; Enzyme Inhibitors; Epilepsy, Temporal Lobe; Hippocampus; Kainic Acid; Male; Mitochondria; NAD; Nitric Oxide; Peroxynitrous Acid; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Signal Transduction; Superoxides; Time Factors; Ubiquinone | 2009 |
Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis.
Topics: Animals; Carbon Monoxide; Disease Models, Animal; DNA, Mitochondrial; Energy Metabolism; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred ICR; Mitochondria, Heart; NAD; Organometallic Compounds; Oxidative Stress; Oxygen Consumption; Peritonitis; Sepsis | 2009 |
Threonine-deficient diets induced changes in hepatic bioenergetics.
Topics: Adenosine Triphosphate; Animal Nutritional Physiological Phenomena; Animals; Body Weight; Dietary Proteins; Disease Models, Animal; Eating; Energy Metabolism; Flavin-Adenine Dinucleotide; Liver; Male; Mitochondria, Heart; Mitochondria, Liver; Myocardium; NAD; Oxidative Phosphorylation; Protein Deficiency; Rats; Rats, Sprague-Dawley; Threonine; Time Factors | 2009 |
Quantifying acute myocardial injury using ratiometric fluorometry.
Topics: Analysis of Variance; Animals; Apoptosis; Biomarkers; Disease Models, Animal; Flavoproteins; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; NAD; Oxidation-Reduction; Rabbits; Spectrometry, Fluorescence | 2009 |
The effects of nicotinamide adenine dinucleotide on intracerebral hemorrhage-induced brain injury in mice.
Topics: Administration, Intranasal; Analysis of Variance; Animals; Brain Edema; Brain Injuries; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; NAD; Neurologic Examination; Neuroprotective Agents | 2009 |
NAD metabolism in HPRT-deficient mice.
Topics: Analysis of Variance; Animals; Blood Proteins; Brain; Disease Models, Animal; Hypoxanthine Phosphoribosyltransferase; Lesch-Nyhan Syndrome; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Purines; Pyridines | 2009 |
Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy.
Topics: Animals; Axons; Chromatography, High Pressure Liquid; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Male; Microscopy, Electron, Transmission; NAD; Nerve Tissue Proteins; Nicotinamide-Nucleotide Adenylyltransferase; Optic Nerve Diseases; Rats; Rats, Wistar; Retinal Ganglion Cells; RNA, Messenger; Statistics, Nonparametric; Stilbamidines; Time Factors; Tumor Necrosis Factor-alpha | 2009 |
Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Apoptosis; Autophagy; bcl-X Protein; Caspase 3; Cells, Cultured; Cytochromes c; Cytokines; Disease Models, Animal; Energy Metabolism; Mice; Mice, Transgenic; Myocardial Ischemia; Myocytes, Cardiac; NAD; Nicotinamide Phosphoribosyltransferase; Rats; Rats, Wistar; Reperfusion Injury; RNA Interference; RNA, Messenger | 2009 |
Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells.
Topics: Animals; Antioxidants; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Gene Expression Regulation; Glucose; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Mice; Mice, Transgenic; NAD; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Tacrolimus; Viral Core Proteins | 2009 |
Mitochondrial function and cerebral blood flow variable responses to middle cerebral artery occlusion.
Topics: Animals; Blood Flow Velocity; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Mitochondria; NAD; Rats; Rats, Wistar; Reperfusion Injury | 2010 |
Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance.
Topics: Animals; Apoptosis; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Guanidines; Humans; Immunoblotting; Mice; Mice, Inbred BALB C; Mice, SCID; N-Myc Proto-Oncogene Protein; NAD; Neovascularization, Pathologic; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Receptor, Platelet-Derived Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
NAD+ auxotrophy is bacteriocidal for the tubercle bacilli.
Topics: Animals; Biosynthetic Pathways; Colony Count, Microbial; Disease Models, Animal; Mice; Microbial Viability; Models, Biological; Mycobacterium bovis; Mycobacterium tuberculosis; NAD; Niacinamide; Tuberculosis; Virulence | 2010 |
Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.
Topics: Aldehyde Reductase; Animals; Cadherins; Diabetic Nephropathies; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Fibrosis; Glucose; Inositol Oxygenase; Kidney Tubules; LLC-PK1 Cells; Male; Mice; Mice, Inbred C57BL; NAD; Phosphorylation; Protein Kinase C-alpha; Protein Prenylation; Protein Transport; raf Kinases; ras Proteins; RNA Interference; Signal Transduction; Swine; Transfection; Transforming Growth Factor beta1; Vimentin | 2010 |
Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Androstadienes; Animals; Benzamides; Benzodioxoles; Blotting, Western; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Enzyme Activation; Enzyme Activators; Estradiol; Female; Indoles; Ketoglutarate Dehydrogenase Complex; Male; Maleimides; Mitochondria, Heart; Mitochondrial Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; Ovariectomy; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proteomics; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sex Factors; Ventricular Function, Left; Ventricular Pressure; Wortmannin | 2010 |
Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy.
Topics: Alleles; Anatomy, Cross-Sectional; Androgen Antagonists; Animals; Behavior, Animal; Bulbo-Spinal Atrophy, X-Linked; Disease Models, Animal; Female; Flutamide; Gene Expression; Male; Mice; Mice, Transgenic; Muscle, Skeletal; NAD; Pregnancy; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Survival | 2011 |
Lysine deacetylation in ischaemic preconditioning: the role of SIRT1.
Topics: Acetylation; Animals; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Lysine; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NAD; Sirtuin 1 | 2011 |
Inhibition of the kynurenine-NAD+ pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis.
Topics: Animals; Animals, Newborn; Apoptosis; Chromatography, High Pressure Liquid; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Hippocampus; Kynurenine; Meningitis, Pneumococcal; Myelin Basic Protein; NAD; Rats; Rats, Wistar; Signal Transduction; Sulfonamides; Thiazoles | 2010 |
Renalase deficiency aggravates ischemic myocardial damage.
Topics: Animals; Base Sequence; Cardiotonic Agents; Disease Models, Animal; DNA Primers; Epinephrine; Female; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase; Myocardial Ischemia; NAD; Norepinephrine; Recombinant Proteins; Renal Insufficiency, Chronic | 2011 |
Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cytoplasm; Disease Models, Animal; Dopamine; Electron Transport Complex I; Mice; Microtubules; NAD; Nerve Degeneration; Parkinson Disease; Reactive Oxygen Species; Rotenone; Substantia Nigra; Vesicular Monoamine Transport Proteins | 2011 |
Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Death; Disease Models, Animal; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Inflammation; Male; NAD; Neutrophils; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Taurine; Transcription Factor RelA | 2012 |
Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Cytosol; Disease Models, Animal; Drug Administration Schedule; Kynurenine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria; MPTP Poisoning; NAD; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Oxidation-Reduction; Substantia Nigra | 2011 |
Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.
Topics: Adenosine Triphosphate; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Cells, Cultured; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Energy Metabolism; Glutathione; Humans; Male; Mice; Mice, Inbred C57BL; NAD; Oxidative Stress; Proteomics; Pyruvate Kinase | 2011 |
Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity.
Topics: Acetylcholine; AMP-Activated Protein Kinases; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Humans; Hypertension; Male; Mice; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; RNA Interference; Time Factors; Transfection; Vasodilation; Vasodilator Agents | 2011 |
Oxidative stress and reduced glutamine synthetase activity in the absence of inflammation in the cortex of mice with experimental allergic encephalomyelitis.
Topics: Analysis of Variance; Animals; Calcium; Cerebral Cortex; Chromatography, High Pressure Liquid; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Glutathione; Glutathione Disulfide; Guinea Pigs; Mice; Myelin Basic Protein; NAD; NADP; Nitric Oxide Synthase Type II; Oxidative Stress; Tandem Mass Spectrometry | 2011 |
Optically measured NADH concentrations are unaffected by propofol induced EEG silence during transient cerebral hypoperfusion in anesthetized rabbits.
Topics: Anesthetics, Intravenous; Animals; Brain; Brain Waves; Cerebrovascular Circulation; Disease Models, Animal; Electroencephalography; Ischemic Attack, Transient; NAD; Neuroprotective Agents; Propofol; Rabbits | 2011 |
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Topics: 4-Chloro-7-nitrobenzofurazan; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Calcium; Cell Death; Coculture Techniques; Deoxyglucose; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; NAD; NADPH Oxidases; Neurons; Oxygen Consumption; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 2011 |
Caloric restriction primes mitochondria for ischemic stress by deacetylating specific mitochondrial proteins of the electron transport chain.
Topics: Acetylation; Animals; Antioxidants; Blotting, Western; Caloric Restriction; Cells, Cultured; Disease Models, Animal; Electron Transport Chain Complex Proteins; Electron Transport Complex III; Humans; Hydrogen Peroxide; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; NADH Dehydrogenase; Niacinamide; Oxidative Stress; Proteomics; Rats; Rats, Inbred F344; Resveratrol; Sirtuins; Stilbenes | 2011 |
Brain energy depletion in a rodent model of diffuse traumatic brain injury is not prevented with administration of sodium lactate.
Topics: Adenosine Triphosphate; Animals; Ascorbic Acid; Aspartic Acid; Blood Gas Analysis; Blood Pressure; Brain Chemistry; Brain Injuries; Cerebral Cortex; Chromatography, High Pressure Liquid; Disease Models, Animal; Energy Metabolism; Glutathione; Male; Models, Biological; NAD; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sodium Lactate | 2011 |
Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.
Topics: Aging; Animals; Circadian Rhythm; Cytokines; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Glucose; Hypoglycemic Agents; Insulin; Lipid Metabolism; Mice; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Sirtuin 1 | 2011 |
Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: attenuation by a lipophilic metalloporphyrin.
Topics: Aconitate Hydratase; Adenine Nucleotides; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Cerebral Cortex; Chromatography, High Pressure Liquid; Coenzyme A; Disease Models, Animal; Electroencephalography; Epilepsy; Fumarate Hydratase; Glutathione; Glutathione Disulfide; Metalloporphyrins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; NAD; Oxidative Stress; Superoxide Dismutase; Tyrosine | 2012 |
NAD(+) administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia.
Topics: Animals; Autophagy; Brain Infarction; Brain Ischemia; Disease Models, Animal; Male; Mice; NAD | 2012 |
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase | 2012 |
A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.
Topics: Adenine Nucleotides; Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Calcium; Cells, Cultured; Cerebral Cortex; Chromatography, High Pressure Liquid; Cytochromes c; Disease Models, Animal; Glutathione; Hippocampus; Humans; Hydrogen Peroxide; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; NAD; Neurons; Niacinamide; Oxidants; Oxidation-Reduction; Presenilin-1; Reactive Oxygen Species; tau Proteins; Vitamin B Complex | 2012 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Dihydroxyacetone Phosphate; Disease Models, Animal; Drug Interactions; Embryo, Mammalian; Fructose-Bisphosphatase; Humans; Huntington Disease; Male; Matrix Metalloproteinase 16; Membrane Proteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; NAD; Neurons; Niacinamide; Nitro Compounds; Oxidopamine; Parkinson Disease; Propionates; Pyruvic Acid; Rats; Rats, Long-Evans; Tyrosine 3-Monooxygenase; Zinc | 2013 |
Establishment of true niacin deficiency in quinolinic acid phosphoribosyltransferase knockout mice.
Topics: Animals; Body Weight; Disease Models, Animal; Eating; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacin; Niacinamide; Pentosyltransferases; Quinolinic Acid | 2012 |
NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy.
Topics: Animals; Antigens, CD; Cell Adhesion; Disease Models, Animal; Dystroglycans; Dystrophin; Extracellular Matrix; Integrin alpha Chains; Integrin alpha6; Laminin; Muscle, Skeletal; Muscular Dystrophies; NAD; Paxillin; Zebrafish; Zebrafish Proteins | 2012 |
Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.
Topics: Adipocytes; Administration, Oral; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Fatty Acid Transport Proteins; Glucose Transporter Type 4; Hypertrophy; Insulin; Islets of Langerhans; Male; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; NAD; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; PPAR gamma; RNA, Messenger; Signal Transduction; Sirtuin 1; Telmisartan; Time Factors; Trans-Activators; Transcription Factors | 2012 |
In a model of Batten disease, palmitoyl protein thioesterase-1 deficiency is associated with brown adipose tissue and thermoregulation abnormalities.
Topics: Adenosine Triphosphate; Adipose Tissue, Brown; Animals; Body Temperature Regulation; Cold Temperature; Disease Models, Animal; Female; Hot Temperature; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; NAD; Neuronal Ceroid-Lipofuscinoses; Neurotransmitter Agents; Proto-Oncogene Proteins c-fos; Receptors, Adrenergic, beta; Thiolester Hydrolases; Uncoupling Protein 1; Ventromedial Hypothalamic Nucleus | 2012 |
NAD(+) maintenance attenuates light induced photoreceptor degeneration.
Topics: Animals; Antioxidants; Cell Death; Cells, Cultured; Circadian Rhythm; Cytoprotection; Disease Models, Animal; Feeding Behavior; Hydrogen Peroxide; Light; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Niacinamide; Nicotinamide-Nucleotide Adenylyltransferase; Oxidants; Oxidative Stress; Photoreceptor Cells, Vertebrate; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Retinal Degeneration; Time Factors; Zinc | 2013 |
A reduced zinc diet or zinc transporter 3 knockout attenuate light induced zinc accumulation and retinal degeneration.
Topics: Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; cis-trans-Isomerases; Diet; Disease Models, Animal; Light; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Retinal Degeneration; Rhodopsin; Time Factors; Tomography, Optical Coherence; Zinc | 2013 |
Optical imaging of mitochondrial redox state in rodent model of retinitis pigmentosa.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Image Processing, Computer-Assisted; Mitochondria; NAD; Optical Imaging; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Retinitis Pigmentosa | 2013 |
Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice.
Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Hypoxia, Brain; Ischemic Preconditioning; Male; Mice; Mice, Transgenic; NAD; Neurons; Nitro Compounds; Propionates; Protein Binding; Recovery of Function; Spectrum Analysis | 2002 |
A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3gamma.
Topics: 14-3-3 Proteins; Adenosine Diphosphate Ribose; Animals; Brain; Brain Injuries; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Enzyme Activation; Enzyme Inhibitors; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proteins; Tyrosine 3-Monooxygenase | 2003 |
Impaired cortical energy metabolism but not major antioxidant defenses in experimental bacterial meningitis.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Ascorbic Acid; Cerebral Cortex; Disease Models, Animal; Energy Metabolism; Free Radicals; Meningitis, Bacterial; NAD; NADP; Oxidative Stress; Pentose Phosphate Pathway; Rats; Rats, Wistar; Streptococcal Infections; Streptococcus pneumoniae | 2003 |
Chronic DNA damage and niacin deficiency enhance cell injury and cause unusual interactions in NAD and poly(ADP-ribose) metabolism in rat bone marrow.
Topics: Alkylating Agents; Animals; Bone Marrow Cells; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Erythrocytes; Ethylnitrosourea; Male; NAD; Neoplasms, Experimental; Niacin; Poly Adenosine Diphosphate Ribose; Random Allocation; Rats; Rats, Long-Evans | 2003 |
Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function.
Topics: Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Disease Models, Animal; Mice; Mice, Inbred BALB C; Mitochondria; NAD; Neuroprotective Agents; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Reperfusion; Stroke | 2003 |
Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia.
Topics: Amino Acids; Ammonia; Animals; Argininosuccinate Synthase; Aspartic Acid; Base Sequence; Citrullinemia; Disease Models, Animal; DNA; Female; Gluconeogenesis; Humans; Liver; Male; Membrane Transport Proteins; Mice; Mice, Knockout; Mitochondrial Membrane Transport Proteins; Mitochondrial Proteins; Mutation; NAD; Phenotype; RNA, Messenger; Urea | 2004 |
Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Catecholamines; Cell Cycle Proteins; Cerebellum; Corpus Striatum; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Dopamine; Mesencephalon; Mice; Mice, Knockout; NAD; NADP; Protein Serine-Threonine Kinases; Psychomotor Performance; Sex Factors; Tumor Suppressor Proteins | 2004 |
p22phox-derived superoxide mediates enhanced proliferative capacity of diabetic vascular smooth muscle cells.
Topics: Animals; Aorta; Base Sequence; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Models, Animal; DNA Primers; Gene Expression Regulation, Enzymologic; Male; Membrane Transport Proteins; Muscle, Smooth, Vascular; NAD; NADH, NADPH Oxidoreductases; NADPH Dehydrogenase; NADPH Oxidases; Oligonucleotides, Antisense; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Transfection; Xanthine | 2004 |
Protection by pyruvate of rat retinal cells against zinc toxicity in vitro, and pressure-induced ischemia in vivo.
Topics: Adenosine Triphosphate; Animals; Cell Culture Techniques; Cell Survival; Chlorides; Cytoprotection; Disease Models, Animal; Intraocular Pressure; Microscopy, Fluorescence; NAD; Neurons, Afferent; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retinal Degeneration; Zinc Compounds | 2004 |
Age-related alteration of brain function during cerebral ischemia.
Topics: Aging; Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Hemodynamics; Male; NAD; Rats; Regional Blood Flow; Reperfusion | 2003 |
A new approach to monitor spinal cord vitality in real time.
Topics: Animals; Blood Pressure; Disease Models, Animal; Ischemia; Male; Monitoring, Physiologic; NAD; Rats; Rats, Wistar; Regional Blood Flow; Reperfusion; Spectrometry, Fluorescence; Spinal Cord | 2003 |
Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
Topics: Animals; Apoptosis; Benzamides; Cardiac Surgical Procedures; Cardioplegic Solutions; Disease Models, Animal; DNA; Enzyme Inhibitors; Heart; Heart Arrest, Induced; Male; Muscle, Smooth, Vascular; Myocardial Reperfusion Injury; Myocardium; NAD; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Function, Left | 2004 |
The effect of rotenone on the urinary ethanol cycle in rats fed ethanol intragastrically.
Topics: Administration, Oral; Alanine Transaminase; Animals; Disease Models, Animal; Drug Antagonism; Drug Therapy, Combination; Ethanol; Liver; Liver Diseases, Alcoholic; Male; NAD; NADH Dehydrogenase; Organ Size; Periodicity; Rats; Rats, Wistar; Rotenone; Uncoupling Agents | 2004 |
In vivo multiparametric monitoring of brain functions under intracranial hypertension following mannitol administration.
Topics: Animals; Blood Pressure; Brain; Cerebrovascular Circulation; Disease Models, Animal; Diuretics, Osmotic; Extracellular Space; Intracranial Hypotension; Intracranial Pressure; Laser-Doppler Flowmetry; Male; Mannitol; Monitoring, Physiologic; NAD; Oxidation-Reduction; Potassium; Protons; Rats; Rats, Wistar; Time Factors | 2005 |
Effect of carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Carbazoles; Carvedilol; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; NAD; Neurons; Poly(ADP-ribose) Polymerases; Propanolamines; Reperfusion Injury; Time Factors | 2005 |
Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains.
Topics: Alcohol Oxidoreductases; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kinetics; Mice; Models, Chemical; NAD; Nifurtimox; Nitroimidazoles; Oxamic Acid; Species Specificity; Time Factors; Trypanocidal Agents; Trypanosoma cruzi; Trypanosomiasis | 2005 |
Effects of anesthesia on the responses to cortical spreading depression in the rat brain in vivo.
Topics: Anesthetics; Animals; Cerebral Cortex; Cerebrovascular Circulation; Chloral Hydrate; Cortical Spreading Depression; Disease Models, Animal; Energy Metabolism; Extracellular Fluid; Magnesium Sulfate; Male; Membrane Potentials; Mitochondria; NAD; Neural Pathways; Neurons; Oxidation-Reduction; Oxygen Consumption; Pentobarbital; Photic Stimulation; Potassium; Rats; Rats, Wistar; Synaptic Transmission; Wakefulness | 2006 |
Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Blood Glucose; Disease Models, Animal; Energy Metabolism; Glutathione; Isoproterenol; Lipid Peroxidation; Male; Mitochondria, Heart; Myocardial Infarction; NAD; NADH Dehydrogenase; Rats; Rats, Wistar; Succinate Dehydrogenase; Succinic Acid; Xanthones | 2006 |
Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Cell Survival; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Hydrogen Peroxide; Male; Middle Cerebral Artery; Molsidomine; NAD; Neuroprotective Agents; PC12 Cells; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2006 |
Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia.
Topics: Administration, Intranasal; Animals; Disease Models, Animal; Ischemic Attack, Transient; Male; Myocardial Infarction; NAD; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley | 2007 |
Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity.
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Drosophila; Mice; Mutant Proteins; NAD; Nerve Degeneration; Neurons; Nicotinamide-Nucleotide Adenylyltransferase; Retina; Wallerian Degeneration | 2006 |
Recruitment of NADH shuttling in pressure-overloaded and hypertrophic rat hearts.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Blood Pressure; Butyrates; Cardiomegaly; Carrier Proteins; Cytosol; Disease Models, Animal; Glycolysis; Heart Rate; Hypertension; Ligation; Magnetic Resonance Spectroscopy; Male; Mitochondria, Heart; Mitochondrial Proteins; NAD; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 2007 |
Hypothyroidism provides resistance to kidney mitochondria against the injury induced by renal ischemia-reperfusion.
Topics: Animals; bcl-2-Associated X Protein; Calcium; Cardiolipins; Cyclosporine; Cytochromes c; Disease Models, Animal; Hypothyroidism; Injections, Intraperitoneal; Kidney; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; NAD; Oxidative Stress; Rats; Reperfusion Injury; Thyroidectomy | 2007 |
Contribution of anaerobic metabolism to reactive hyperemia in skeletal muscle.
Topics: Anaerobic Threshold; Animals; Blood Flow Velocity; Blood Pressure; Cats; Disease Models, Animal; Hyperemia; Hypoxia; Microscopy, Fluorescence; Microscopy, Video; Muscle, Skeletal; NAD; Regional Blood Flow; Spectrometry, Fluorescence; Time Factors; Vasodilation; Vasodilator Agents; Venules | 2007 |
The guinea-pig is a poor animal model for studies of niacin deficiency and presents challenges in any study using purified diets.
Topics: Animals; Bone Marrow; Caseins; Dietary Supplements; Disease Models, Animal; Gelatin; Guinea Pigs; Humans; Male; NAD; Niacin; Survival Analysis; Tryptophan; Weight Gain | 2007 |
Inhibitors of metabolism rescue cell death in Huntington's disease models.
Topics: Adenosine Triphosphate; Animals; Caspases; Cell Death; Cell Line; Disease Models, Animal; Drosophila melanogaster; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glycolysis; Huntington Disease; Mitochondria; Mutation; NAD; Neurons; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Rotenone; Signal Transduction | 2007 |
Effect of polyphenol-containing azuki bean (Vigna angularis) extract on blood pressure elevation and macrophage infiltration in the heart and kidney of spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Fabaceae; Flavonoids; Heart; Heart Rate; Hypertension; Kidney; Macrophages; Myocardium; NAD; Phenols; Plant Extracts; Polyphenols; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides; Thiobarbituric Acid Reactive Substances; Time Factors | 2008 |
Locations of ectopic beats coincide with spatial gradients of NADH in a regional model of low-flow reperfusion.
Topics: Animals; Body Surface Potential Mapping; Cardiac Complexes, Premature; Chromatography, High Pressure Liquid; Coronary Circulation; Disease Models, Animal; Fluorescence; Heart Rate; Male; Membrane Potentials; Myocardial Ischemia; Myocardium; NAD; Perfusion; Pericardium; Rats; Rats, Sprague-Dawley; Research Design; Time Factors | 2008 |
Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation.
Topics: Animals; Blood Transfusion; Blood Viscosity; Blood Volume; Capillaries; Disease Models, Animal; Erythrocyte Transfusion; Hemoglobins; Humans; Hydroxyethyl Starch Derivatives; Microcirculation; NAD; Oxygen; Polyethylene Glycols; Raffinose; Resuscitation; Shock, Hemorrhagic; Vasoconstriction | 2008 |
Differences in the neurotoxic effects of manganese during development and aging: some observations on brain regional neurotransmitter and non-neurotransmitter metabolism in a developmental rat model of chronic manganese encephalopathy.
Topics: Acetylcholinesterase; Aging; Animals; Brain Chemistry; Choline; Chronic Disease; Disease Models, Animal; Energy Metabolism; Glucosephosphate Dehydrogenase; Isocitrate Dehydrogenase; Manganese Poisoning; NAD; Nervous System Diseases; Neurotransmitter Agents; Rats; Synaptosomes | 1984 |
[Xanthine oxidase activity: O2-dependent and NAD+-dependent forms in the liver, in rats with adjuvant arthritis and hepatitis].
Topics: Aerobiosis; Animals; Arthritis; Arthritis, Experimental; Cytosol; Disease Models, Animal; Hepatitis; Liver; Male; NAD; Oxygen; Rats; Rats, Inbred Strains; Xanthine Oxidase | 1983 |
[Exchange reactions in brain tissue under chronic ethanol intoxication].
Topics: Alcohol Oxidoreductases; Alcoholism; Animals; Brain; Citric Acid Cycle; Disease Models, Animal; Ethanol; Humans; NAD; NADP; Rabbits | 1982 |
Intestinal ischemia during hypoxia and experimental sepsis as observed by NADH videofluorimetry and quenching of Pd-porphine phosphorescence.
Topics: Animals; Disease Models, Animal; Energy Metabolism; Fluorometry; Hypoxia; Intestinal Mucosa; Intestines; Ischemia; Luminescent Measurements; Male; Mesoporphyrins; Metalloporphyrins; NAD; Oxygen; Palladium; Rats; Rats, Wistar; Sepsis; Shock, Septic | 1994 |
Nicotinamide megadosing increases hepatic poly(ADP-ribose) levels in choline-deficient rats.
Topics: Animal Nutritional Physiological Phenomena; Animals; Choline; Choline Deficiency; Disease Models, Animal; Dose-Response Relationship, Drug; Food, Fortified; Liver; Male; Methionine; NAD; Niacinamide; Poly Adenosine Diphosphate Ribose; Random Allocation; Rats; Rats, Inbred F344 | 1995 |
Niacin attenuates acute lung injury induced by lipopolysaccharide in the hamster.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cricetinae; Disease Models, Animal; Endotoxins; Escherichia coli; Lipopolysaccharides; Male; Mesocricetus; NAD; Niacin; Respiratory Distress Syndrome | 1994 |
Brain pHi, cerebral blood flow, and NADH fluorescence during severe incomplete global ischemia in rabbits.
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Glucose; Hydrogen-Ion Concentration; Mitochondria; NAD; Neurons; Rabbits; Regional Blood Flow; Umbelliferones; Xenon Radioisotopes | 1993 |
Multiparameter monitoring and analysis of in vivo ischemic and hypoxic heart.
Topics: Animals; Cardiomegaly; Coronary Circulation; Disease Models, Animal; Dogs; Electrodes; Female; Fiber Optic Technology; Fluorometry; Hypoxia; Male; Myocardial Ischemia; Myocardium; NAD; Oxidation-Reduction; Perfusion | 1996 |
Skeletal muscle metabolism in experimental heart failure.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Disease Models, Animal; Female; Heart Failure; Monocrotaline; Muscle, Skeletal; NAD; Organ Size; Oxidation-Reduction; Phosphocreatine; Rats; Rats, Sprague-Dawley | 1996 |
Inhibition of nitric oxide synthesis aggravates myocardial ischemia in hemorrhagic shock in constant pressure model.
Topics: Adenosine Triphosphate; Animals; Aorta; Catecholamines; Disease Models, Animal; Dogs; Enzyme Inhibitors; Fluorescence; Freezing; Hemodynamics; Lactic Acid; Myocardial Ischemia; NAD; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen; Shock, Hemorrhagic | 1998 |
Peroxynitrate-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat.
Topics: Animals; Benzamides; Disease Models, Animal; DNA Damage; Energy Metabolism; Enzyme Activation; Macrophages, Peritoneal; Male; Mitochondria; NAD; NG-Nitroarginine Methyl Ester; Niacinamide; Nitrates; Nitric Oxide Synthase; Oxidants; Oxygen Consumption; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Shock; Zymosan | 1998 |
Regulation of mitochondrial [NADH] by cytosolic [Ca2+] and work in trabeculae from hypertrophic and normal rat hearts.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiomegaly; Cytosol; Diastole; Disease Models, Animal; Electric Stimulation; Electrophysiology; Fluorescent Dyes; Hypertension; In Vitro Techniques; Indoles; Male; Mitochondria; Myocardium; Myofibrils; NAD; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Systole | 1998 |
Cardiorespiratory, tissue oxygen and hepatic NADH responses to graded hypoxia.
Topics: Animals; Blood Gas Analysis; Cell Hypoxia; Disease Models, Animal; Hemodynamics; Hypoxia; Liver; Male; NAD; Oxygen Consumption; Random Allocation; Rats; Rats, Sprague-Dawley; Survival Analysis | 1998 |
Protective effect of N-acetylcysteine on cellular energy depletion in a non-septic shock model induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Cell Membrane Permeability; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Energy Metabolism; Free Radical Scavengers; Macrophages, Peritoneal; Male; NAD; Nitrates; Nitric Oxide; Rats; Rats, Sprague-Dawley; Sepsis; Shock; Tyrosine; Zymosan | 1999 |
Quinone analogue irrecoverably paralyses the filarial parasites in vitro.
Topics: Animals; Benzoquinones; Cattle; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport; Filariasis; Fumarates; Glucose; Humans; Malates; Movement; NAD; Setaria Nematode; Setariasis; Sodium Lactate; Time Factors; Wuchereria bancrofti | 1999 |
Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Resistance; Insulin; Islets of Langerhans; Mice; Mice, Inbred C57BL; NAD; Poly(ADP-ribose) Polymerases; Streptozocin | 1999 |
A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy.
Topics: Acetaldehyde; Actins; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Alcoholic; Disease Models, Animal; Ethanol; L-Lactate Dehydrogenase; Mice; Mice, Transgenic; Microscopy, Electron; Myocardial Contraction; NAD; RNA, Messenger; Time Factors | 1999 |
Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan-induced shock.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Energy Metabolism; Free Radical Scavengers; Immunohistochemistry; L-Lactate Dehydrogenase; Lung; Male; Malondialdehyde; Metalloporphyrins; NAD; Nitrates; Peroxidase; Rats; Rats, Sprague-Dawley; Shock; Superoxide Dismutase; Tyrosine; Zymosan | 1999 |
Pretransplantation assessment of renal viability with NADH fluorimetry.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Fluorometry; Graft Rejection; Graft Survival; Ischemia; Kidney; Kidney Diseases; Kidney Transplantation; Kinetics; Male; Mitochondria; NAD; Nephrectomy; Oxidation-Reduction; Predictive Value of Tests; Rats; Rats, Inbred Strains | 2000 |
Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia.
Topics: Animals; Benzamides; Blotting, Northern; Blotting, Western; Cell Death; Cell Survival; Disease Models, Animal; DNA Repair; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hippocampus; Immunohistochemistry; In Situ Hybridization; Ischemic Attack, Transient; Male; NAD; Neurons; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stroke | 2000 |
Effect of transient focal ischemia of mouse brain on energy state and NAD levels: no evidence that NAD depletion plays a major role in secondary disturbances of energy metabolism.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Brain; Disease Models, Animal; Energy Metabolism; Fluorescence; Ischemic Attack, Transient; Luminescent Measurements; Male; Mice; Mice, Inbred C57BL; NAD; Organ Specificity; Poly(ADP-ribose) Polymerases | 2000 |
Transmyocardial revascularization aggravates myocardial ischemia around the channels in the immediate phase.
Topics: Analysis of Variance; Animals; Blood Flow Velocity; Coronary Circulation; Disease Models, Animal; Dogs; Laser Therapy; Microspheres; Myocardial Ischemia; Myocardial Revascularization; Myocardium; NAD; Postoperative Period; Regression Analysis; Spectrometry, X-Ray Emission | 2000 |
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Topics: Adenosine Triphosphatases; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Electron Transport Complex IV; Electrophoresis, Polyacrylamide Gel; Male; Melatonin; Mitochondria; Motor Activity; NAD; Neuroprotective Agents; Oxidative Phosphorylation; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2001 |
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
Topics: Amino Acid Sequence; Animals; Antimalarials; Disease Models, Animal; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Malaria; Mice; Mice, Inbred BALB C; Molecular Sequence Data; NAD; Oxidoreductases; Plasmodium berghei; Plasmodium falciparum; Triclosan | 2001 |
Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation.
Topics: Acute Disease; Animals; Carrageenan; Disease Models, Animal; DNA Damage; Energy Metabolism; Enzyme Activation; Inflammation; Macrophages; Male; Melatonin; NAD; Peroxynitrous Acid; Pleurisy; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley | 2001 |
Multiparametric monitoring of brain under elevated intracranial pressure in a rat model.
Topics: Animals; Brain; Calcium; Cerebrovascular Circulation; Cisterna Magna; Disease Models, Animal; Homeostasis; Hydrogen-Ion Concentration; Intracranial Hypertension; Laser-Doppler Flowmetry; Male; Mitochondria; NAD; Oxidation-Reduction; Potassium; Rats; Rats, Wistar | 2001 |
Is a NAD pyrophosphatase activity necessary for Haemophilus influenzae type b multiplication in the blood stream?
Topics: Animals; Bacteremia; Bacterial Proteins; Culture Media; Disease Models, Animal; Factor V; Haemophilus Infections; Haemophilus influenzae type b; Humans; Multienzyme Complexes; Mutation; NAD; Nucleotidases; Pyrophosphatases; Rats; Virulence | 2001 |
Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury.
Topics: Animals; Cell Survival; Cytokines; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Intercellular Adhesion Molecule-1; Isoquinolines; Mice; Mice, Inbred BALB C; NAD; P-Selectin; Peroxynitrous Acid; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Respiratory Distress Syndrome; Up-Regulation | 2002 |
Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxyacyl CoA Dehydrogenases; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Protein Precursor; Animals; Base Sequence; Binding Sites; Cloning, Molecular; Disease Models, Animal; DNA, Complementary; Hippocampus; Humans; Mice; Mice, Transgenic; Mitochondria; Molecular Sequence Data; NAD; Presynaptic Terminals; Protein Isoforms; Protein Structure, Tertiary; Signal Transduction; Steroids; Tryptophan | 2002 |
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Enzyme Activation; Guanylate Cyclase; In Vitro Techniques; Infusions, Parenteral; Membrane Glycoproteins; Membrane Transport Proteins; Microfilament Proteins; NAD; NADH, NADPH Oxidoreductases; NADP; NADPH Dehydrogenase; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphoproteins; Protein Kinase C; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Superoxides; Vasodilation; Vasodilator Agents | 2002 |
Lactic acidosis: an experimental model.
Topics: Acidosis; Animals; Bicarbonates; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Disease Models, Animal; Hydrogen-Ion Concentration; Hydroxybutyrates; Lactates; NAD; Pyruvates; Rabbits | 1976 |
Cerebral hemodynamic and metabolic alterations in stroke.
Topics: Animals; Basal Ganglia; Bicarbonates; Brain; Carbon Dioxide; Cats; Cerebrovascular Disorders; Disease Models, Animal; Glucose; Haplorhini; Humans; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Models, Biological; NAD; Oxidation-Reduction; Oxygen Consumption; Papio; Regional Blood Flow | 1977 |
Failure of nicotinamide in the treatment of hemorrhagic shock.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Kidney; Liver; NAD; Niacinamide; Nicotinic Acids; Oxidative Phosphorylation; Rats; Shock, Hemorrhagic | 1976 |
Coenzyme alterations in rats with experimental hypertension.
Topics: Adrenal Medulla; Adrenalectomy; Animals; Arteries; Disease Models, Animal; Female; Hypertension; Hypertension, Renal; Kidney; Liver; Male; NAD; Nephrectomy; Oxidation-Reduction; Prostaglandins E; Rats; Rats, Inbred Strains; Sodium Chloride | 1976 |
NAD glycohydrolase activity in hearts with acute experimental infarction.
Topics: Animals; Disease Models, Animal; Dogs; Myocardial Infarction; Myocardium; NAD; NAD+ Nucleosidase; Niacinamide | 1976 |
Experimental phenylketonuria: metabolic studies in rat liver.
Topics: Animals; Disease Models, Animal; Fasting; Female; Fenclonine; Fructosephosphates; Gluconeogenesis; Glucose; Glucosephosphates; Humans; Hydroxybutyrate Dehydrogenase; Ketone Bodies; L-Lactate Dehydrogenase; Liver; Malate Dehydrogenase; NAD; Phenylalanine; Phenylketonurias; Rats; Stereoisomerism | 1977 |
GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve.
Topics: Animals; Axons; Cell Count; Cell Survival; Disease Models, Animal; G(M1) Ganglioside; Injections, Intraperitoneal; Male; NAD; Nerve Degeneration; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence | 1992 |
Brain vasculature and mitochondrial responses to ischemia in gerbils. I. Basic anatomical patterns and biochemical correlates.
Topics: Animals; Brain; Brain Ischemia; Circle of Willis; Disease Models, Animal; Fluorometry; Gerbillinae; Mitochondria; NAD; Oxidation-Reduction; Rats; Seizures | 1992 |
A study of galactose intolerance in human and rat liver in vivo by 31P magnetic resonance spectroscopy.
Topics: Adenosine Triphosphate; Adult; Animals; Child; Disease Models, Animal; Female; Galactose; Galactosemias; Galactosephosphates; Humans; Liver; Magnetic Resonance Spectroscopy; Male; NAD; Phosphates; Rats; Rats, Inbred Strains; Uridine Diphosphate Galactose | 1992 |
Sepsis does not impair tricarboxylic acid cycle in the heart.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Citric Acid Cycle; Disease Models, Animal; Female; Heart; Heart Rate; Hematocrit; Magnetic Resonance Spectroscopy; Myocardium; NAD; NADP; Phosphocreatine; Phosphorus; Rats; Rats, Inbred Strains; Reference Values; Sepsis | 1991 |
[Effect of nucleotide anti-aggregants (NAD, AMP) and ischemia on the tissue blood coagulation factors].
Topics: Adenosine Monophosphate; Animals; Blood Coagulation; Disease Models, Animal; Ischemia; Kidney; Male; NAD; Platelet Aggregation Inhibitors; Rabbits; Rats; Thromboplastin | 1991 |
Regional ischemia in cerebral venous hypertension due to embolic occlusion of the superior sagittal sinus in the rat.
Topics: Animals; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Hypertension; Male; NAD; Rats; Rats, Inbred Strains; Sinus Thrombosis, Intracranial | 1990 |
[Tissue pH and energy metabolism in cerebral embolization model of rat].
Topics: Acute Disease; Adenosine Triphosphate; Animals; Brain; Brain Edema; Disease Models, Animal; Energy Metabolism; Hydrogen-Ion Concentration; Intracranial Embolism and Thrombosis; Luminescent Measurements; NAD; Rats; Rats, Inbred Strains | 1990 |
Alterations of fasting glucose and fat metabolism in intrauterine growth-retarded newborn dogs.
Topics: Aging; Alanine; Animals; Animals, Newborn; Blood Glucose; Disease Models, Animal; Dogs; Energy Metabolism; Fasting; Fatty Acids, Nonesterified; Female; Fetal Growth Retardation; Glucose; Ketone Bodies; Lactates; Liver; Liver Glycogen; NAD; Pregnancy; Reference Values; Triglycerides | 1989 |
Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats. An animal model of impaired oxidative phosphorylation (mitochondrial myopathy).
Topics: Administration, Oral; Animals; Cytochromes; Disease Models, Animal; Hypoglycemic Agents; Male; Mitochondria; Muscles; Muscular Diseases; NAD; Onium Compounds; Oxidative Phosphorylation; Pyruvate Dehydrogenase Complex; Rats; Rats, Inbred Strains | 1988 |
Effect of coenzyme-A, NAD, alpha lipoic-acid and cocarboxylase on survival of rats with galactosamine-induced severe hepatitis.
Topics: Animals; Coenzyme A; Disease Models, Animal; Female; Galactosamine; Hepatitis; Liver Function Tests; NAD; Rats; Rats, Inbred Strains; Thiamine Pyrophosphate; Thioctic Acid | 1985 |
Neurologic deficit, blood flow and biochemical sequelae of reversible focal cerebral ischemia in cats.
Topics: Adenosine Triphosphate; Animals; Brain; Cats; Disease Models, Animal; Female; Glucose; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Male; NAD; Regional Blood Flow | 1985 |
Studies of the spontaneous myocardiopathy in the BIO-14.6 strain of hamster.
Topics: Acid Phosphatase; Adenine Nucleotides; Adenosine Triphosphatases; Animals; Biological Transport, Active; Cardiomyopathies; Cricetinae; Disease Models, Animal; Endoplasmic Reticulum; Female; Heart Valves; Lipid Metabolism; Male; Microscopy, Electron; Mitochondria, Muscle; Myocardium; Myofibrils; NAD; Oxidoreductases; Sarcolemma | 1970 |
Cardiac failure in the hamster. A biochemical and electron microscopic study.
Topics: Animals; Cardiomegaly; Cricetinae; Disease Models, Animal; DNA; Glucosephosphate Dehydrogenase; Glycerolphosphate Dehydrogenase; Heart Failure; Heart Ventricles; Hexokinase; Microscopy, Electron; Mitochondria, Muscle; Mitochondrial Swelling; Myocardium; NAD; Necrosis; Phosphofructokinase-1; Phosphogluconate Dehydrogenase; Pyruvate Kinase; Rodent Diseases; Sarcoplasmic Reticulum | 1972 |
Relation between changes in the acid-base and the energy metabolism of the brain in hepatic coma.
Topics: Acid-Base Equilibrium; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Bicarbonates; Brain; Carbon Dioxide; Disease Models, Animal; Hemoglobins; Hepatectomy; Hepatic Encephalopathy; Hydrogen-Ion Concentration; Lactates; Male; NAD; Oxygen; Partial Pressure; Phosphocreatine; Pyruvates; Rats | 1971 |
Measurements of extracellular potassium, ECoG and pyridine nucleotide levels during cortical spreading depression in rats.
Topics: Animals; Cerebral Cortex; Cortical Spreading Depression; Disease Models, Animal; Electroencephalography; Extracellular Space; Male; Microscopy, Fluorescence; NAD; Potassium; Rats | 1974 |
Effects of pyrazole on ethanol-induced changes in hepatic triglyceride and glycerol-1-phosphate contents and on esterified and non-esterified fatty acids in the blood.
Topics: Animals; Disease Models, Animal; Esters; Ethanol; Fatty Acids, Nonesterified; Fatty Liver; Female; Glycerophosphates; Liver; Mice; NAD; Pyrazoles; Triglycerides | 1974 |
Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
Topics: Alloxan; Animals; Carbon Radioisotopes; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Islets of Langerhans; Male; Mice; NAD; Nitrosourea Compounds; Streptozocin; Time Factors | 1974 |
Regional bioenergetic events in the experimental glioblastoma. Aquantitative histochemical study.
Topics: Adenosine Triphosphate; Animals; Brain Neoplasms; Disease Models, Animal; Fluorometry; Freezing; Glioblastoma; Glucose; Glycogen; Histocytochemistry; Lactates; Mice; NAD; NADP; Neoplasm Transplantation; Neoplasms, Experimental; Neuroglia; Oxygen Consumption; Pentoses; Phosphates; Phosphocreatine; Transplantation, Homologous | 1971 |
Critical oxygen tensions in the brain.
Topics: Adenine Nucleotides; Animals; Brain; Brain Chemistry; Disease Models, Animal; Hypoxia; Lactates; NAD; NADP; Oxygen; Oxygen Consumption; Partial Pressure; Phosphocreatine; Pyruvates; Rats | 1971 |